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ABSTRACT 
Brucella abortus strain RB51, a naturally derived rough variant, 
has been proposed to replace strain 19 for use as a vaccine against 
brucellosis in cattle. Utilizing fingerprinting and standard biotyping 
techniques, it was possible to differentiate RB51 from other brucellae 
and to ascertain the stability of RB51. Standardization of a genomic 
fingerprinting procedure using restriction endonuclease profiles of total 
DNA from Brucella are described. Although the focus was principally on 
B. abortus isolates from cattle, the investigation included field 
isolates from bison and elk, reference strains, vaccinal strains, and 
genetically-engineered brucellae. 
Pulsed-field gel electrophoresis profiles of the reference type 
strains allowed separation of the strains to the level of species. A 
unique fingerprint relative to other brucellae was discovered for RB51, 
using profiles of genomic DNA digested with the restriction endonuclease 
Xba I. 
Stability of RB51 after animal passage and high passage on 
artificial media was determined using standard methods for characterizing 
brucellae. Techniques included biochemical, morphological, antigenic, 
phage susceptibility, and antibiotic resistance. RB51 retained rough 
colonial morphology with no detectable 0-antigen of Brucella 
lipopolysaccharide and remained resistant to rifampin or to penicillin 
and sensitive to tetracycline following repeated passage. No detectable 
changes in characteristic oxidative metabolic profiles on selected amino-
acid or carbohydrate substrates were demonstrated following in vivo or 
repeated in vitro passage. 
Genomic fingerprints of reference strains and biovars of Brucella 
were analyzed to obtain information on the genetic relatedness among the 
strains. Included were four newly described isolates of Brucella from 
the common seal, harbor porpoise, and common dolphins. Distance matrix 
vii 
analyses were done and a dendrogram was constructed. Results support the 
designation of an additional genomic group(s) of Birucella.. 
Comparison of cell wall structure of RB51 and B. abortus strain 
2308 using transmission electron microscopy revealed variation in surface 
properties indicating modifications in acidic polysaccharide associated 
with lipopolysaccharide. The ultrastruetural characteristics of the cell 
wall contributes to the understanding of B. abortus by demonstrating 
surface components that may be involved in cellular interactions. 
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GENERAL INTRODUCTION 
Brucella abortus is a bacterial pathogen that causes acute and 
chronic infections in both animals and humans. In bovidae, brucellosis 
is most often assjraiptomatic though in the pregnant female infection of 
reproductive organs leads to placentitis characterized by abortion during 
late gestation, retention of placenta, delivery of weak calves, or 
infertility of the cow. In the bull, orchitis and epididymitis occur. 
Persistent infection is common with this bacterivun with shedding in 
reproductive and mammary secretions. Because of economic impact on 
animal health and the risk of debilitating human disease, Brucella is 
significantly important. 
Vaccination of cattle with B. abortus strain 19 in conjunction with 
other disease control and eradication procedures have resulted in 
declining prevalence of bovine brucellosis in the United States. Strain 
19 vaccination enhances resistance to infection with B. abortus by 
limiting growth of the bacteria in the uterus and mammary glands, thereby 
lessening the occurrence of abortion and the secretion of virulent 
brucellae in milk when compared with non-vaccinated animals. However, 
the acquired immunity is transient and vaccination with strain 19 does 
not give total protection. Abortion may result when pregnant cattle are 
vaccinated with strain 19. Additionally, the vaccine may cause 
persistent infections in vaccinated cattle or induce antibodies which 
interfere with interpretation of serological tests used for detecting 
natural-infected animals. Strain 19 is also infectious to humans. 
Brucella abortus strain RB51 has been proposed as a vaccine to 
replace strain 19 which is currently used in the National Brucellosis 
Eradication Program. Strain RB51 is a stable rough mutant of B abortus 
strain 2308 that lacks 0-side chain of lipopolysaccharide. Cattle 
vaccinated with RB51 are protected from abortion, and have humoral and 
cell-mediated immune responses similar to those of cattle vaccinated with 
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strain 19. However, unlike strain 19, RB51-vaccinates do not produce 
antibodies that react immunologically in routine diagnostic tests used 
for detecting naturally acquired brucellosis. 
Characteristics for separating a vaccine strain from field strains 
make the vaccine against Brucella more attractive for use in eradication 
programs. It is desirable for the vaccine to elicit antibody responses 
that are distinguishable from that evoked by virulent field strains. 
Phenotjrpic and genetic characteristics are used as epidemiological 
markers that are prerequisite for differentiating the vaccine strain from 
field strains. These markers are beneficial for discriminating the 
vaccine strain in areas where outbreaks of brucellosis occur from a wild 
animal reservoir or imported cattle. 
Standard restriction endonuclease (RE) analysis of Brucella DNA, 
using high-cleavage-frequency RE has provided little assistance in 
differentiating Brucella from among each other. High frequency cutting 
RE reveal very little differences between the strains due to the high 
number of generated fragments for electrophoretic patterns to be easily 
distinguishable. Genomic DNA fingerprinting using pulsed-field gel 
electrophoresis (PFGE) with low frequency cutting RE has been suscessful 
as a method of species and strain identification applicable for bacterial 
pathogens. Recently, PFGE has been used to demonstrate DNA polymorphisms 
in the genomic structure among Brucella species. 
The objectives of this study were to evaluate genomic 
fingerprinting techniques for use in differentiating the proposed vaccine 
B. abortus strain RB51 from other Brucella, and to obtain Information on 
the stability of B. abortus strain RB51 by genomic fingerprinting, 
oxidative metabolism, and colonial morphology. Emphasis was on the 
analysis of B. abortus which included isolates from cattle, bison, and 
elk, vaccine strains, natural mutants, and type strains as well as 
genetic-engineered brucellae. In addition. Brucella isolated from seal, 
porpoise, and dolphins were included for comparison in this study. 
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The investigation consisted of an integrated molecular, restriction 
endonuclease analysis, immunochemical, biophysical, and ultrastructural 
approach on characterization of B. abortus strain RB51. Reference 
strains of Brucella species and biovars from the World Health 
Organization (WHO) and Food and Agriculture Organization (FAO) were 
examined. Strain RB51 was compared with bacteriologic characterization 
of Brucella species isolated from cattle, bison, and elk. Genomic RE 
patterns produced by PFGE were determined. 
Genomes of brucellae were isolated following treatment using 0.5 M 
EDTA containing sodium dodecyl sulfate and pronase, and then digested 
with the RE, Xba I. Fragments of digested DNA were separated using PFGE 
techniques. DNA was stained with ethidixim bromide to visualize fragment 
patterns. Patterns were then compared to determine similarities and 
differences. 
Manometric techniques were used to determine oxygen uptake for 
strain RB51. Metabolism on selected amino acid and carbohydrate 
substrates was assessed by volumetric measurements of oxygen consvimption 
using the Warburg respirometer. The oxidative metabolic profile of RB51 
was compared to those from other brucellae. The oxidative metabolic 
rates of RB51 after time in vivo and in vitro were examined. 
Brucella abortus strains RB51 (rough) and 2308 (smooth) were 
characterized using transmission electron microscopy. Cell wall 
structure was analyzed using negative staining with phosphotungstic acid 
and thin-section techniques which included glutaraldehyde-osmium, 
ruthenium red, alcian blue, and osmium staining procedures. All 
preparations were examined with a Philips 410 electron microscope 
(Philips Electronic Institute Inc., Mahwah, NJ) at an accelerating 
voltage of 60 kV. 
Results of this study provides information for vaccine verification 
and diagnostic development concerning infections attributed to B. abortus 
in cattle, bison, and elk. The genomic fingerprinting technique which 
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was developed contributes to the identification and differentiation of 
the proposed vaccine B. abortus strain RB51 and would be beneficial in 
characterizing specific Brucella isolates. This study also demonstrated 
stability of the organism (RB51) after time in vivo and in vitro. 
Dissertation organization 
This dissertation is presented in the alternate format and consists 
of four manuscripts in the style of the American Society for 
Microbiology. The first manuscript has been published in the American 
Journal of Veterinary Research. The other three manuscripts will be 
submitted for publication. A review of the literature precedes the first 
manuscript and a general summary and discussion follows the last 
manuscript. A list of references appears at the end of each manuscript. 
Literature cited in the literature review is located after the general 
summary and discussion. The candidate was the principal investigator and 
author for each manuscript presented. 
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LITERATURE REVIEW 
Bovine Bmicellosis 
Brucellosis is an economically important disease in the cattle 
industry. Economic losses are attributed to the loss of calves, 
decreased milk yields in dairy cattle, arthritis or bursitis, and 
decreased fertility. It has been estimated that infected cows have 20% 
lower milk production and 40% fewer calves than brucellosis-free herds 
(41). The disease is caused by the bacterium Brucella abortus, and 
sometimes by 5. melitensis or B. suis. Of these species, B. abortus is 
the major concern for the epidemic disease in cattle. Occasionally, 
sheep and goats become infected after contact with Brucella-infected 
cattle. 
Brucella abortus causes acute and chronic infections in both 
animals and humans. In bovidae, brucellosis is most often asymptomatic; 
however, the pregnant heifer is extremely susceptible. Principle 
manifestation of bovine brucellosis is reproductive failure. This is 
characterized by premature expulsion of the fetus (abortion) during late 
gestation, retention of the placenta, delivery of weak calves, or 
infertility of the cow; orchitis and epididymitis occur with frequent 
sterility in the bull. Cows usually recover spontaneously, but excrete 
Brucella for varying amounts of time in body fluids (uterine discharges, 
milk, urine). 
Cattle become infected by contact with discharge from pregnant 
animals at time of abortion, or by consumption of contaminated forage. 
Large numbers of brucellae are disseminated into the environment at 
parturition, at which time oral exposure is the primary route (72). 
Brucella may also spread venereally though sexual contact or orally via 
milk. Brucella has been shown to survive on shaded pasture for 100 days 
(71). 
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Infection usually begins through the gastrointestinal tract, skin, 
or mucous membranes. Successive pathogenic steps include: 1) passage 
through mucous membranes, 2) drainage into the lymph system with 
colonization of nodes, and 3) dissemination through blood to main organs 
of the reticuloendothelial system and on occasion to certain target 
organs such as the uterus and placenta. Infection of the gravid uterus 
results in placentitis, fetal death and abortion, or delivery of weak 
calves (81). 
Brucellae penetrate the mucosa of nasal, oral, or pharyngeal 
cavities (56). After penetrating the mucosal epithelium, bacteria are 
transported (free or within phagocytes) to regional Ijrmph nodes which 
become enlarged due to lymphatic and reticuloendothelial hyperplasia and 
inflammation (22). Brucellae survive as facultative intracellular 
bacteria within both neutrophils and macrophages of the 
reticuloendothelial system (i.e., Ijnnph nodes, spleen, liver, bone 
marrow) where they are protected from antibody, complement, and 
antibiotics (33, 78, 79). Brucella abortus can inhibit degranulation and 
phagolysosomal fusion, and resist lysosomal enzyme activity (10, 20, 46, 
84). Normally, mononuclear phagocytes, tissue macrophages, and fixed 
phagocytes of the reticuloendothelial system play an important role in 
destruction of facultative intracellular organisms. Regardless, 
brucellae proliferate, phagocytes subsequently lyse, and mononuclear 
cells become infected. 
Brucella can localize and replicate in cisternae of the rough 
endoplasmic reticulum of placental trophoblastic epithelial cells (6, 7) 
and nonphagocytic host cells (36, 37, 63). Transfer of B. abortus from 
phagosomes to rough endoplasmic reticulum may require endosomal 
acidification (38). Replication of B. abortus within the rough 
endoplasmic reticulum may be influenced by protein synthesis of the host 
cell. 
Brucellae become hematogenous spreading to the liver, spleen, bone 
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marrow, lymph nodes, mammary glands, and the pregnant uterus. In 
tissues, the inflammatory response becomes granulomatous as monocytes and 
macrophages phagocytize bacteria (95). Discreet foci of infection may 
persist that are relatively inaccessible to humoral and cellular immune 
defenses. Micro- or macro- abscesses, granulomatous lesions, or foci in 
cysts and glandular follicles, bone marrow, etc., may continuously or 
intermittently release organisms, endotoxin (lipopolysaccharide), and 
other products into the general circulations. Brucella has a marked 
predilection for the chorioallantoic trophoblasts (91) suggestive of 
cellular trophism. The placenta is the primary site where replication of 
Brucella, is greatest. Mechanisms of trophoblast trophism and placental 
localization in bovine brucellosis are poorly understood. Brucellae may 
localize because of available nutrients and/or enzjnnes needed as 
precursors of DNA or protein synthesis, translation, or other metabolic 
processes. 
Historical background 
Bovine brucellosis has been referred to as contagious abortion, 
infectious abortion, abortion disease, epizootic abortion, Bang's 
disease, and "slinking of calves". Other names for the causative 
organism (5. abortus) include: "Bacterium abortus", "Bacillus abortus", 
"Bang's bacillus", and "Corynebacterium abortus infectiosi". In 1897, 
Bang (9), a veterinarian in Copenhagen, was the first to describe B. 
abortus as the causative agent of bovine brucellosis. He isolated the 
organism from abortion products of cattle and demonstrated the infectious 
nature of the disease by placing vaginal discharge and fetal membranes 
into vaginas of healthy cows. 
Brucella causes acute or chronic infections in humans and has been 
called brucellosis, undulant fever, Malta fever, Mediterranean fever, or 
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Bang's disease. The association of Brucella organisms (B. melitensis) 
with brucellosis in man was first described in 1887 by Sir David Bruce 
(18), a British military physician stationed on the Mediterranean island 
of Malta. While on the island, he succeeded in culturing the organism 
from the spleens of four soldiers who died of Malta fever. 
In the United States, brucellosis in humans is usually due to 
direct contact with Brucella-infected animals or by contaminated food 
products. Human to human transmission of the disease does not occur. 
Although venereal transmission has not been documented, B. melitensis has 
been isolated from fresh and frozen htaman sperm (107). Detection of the 
disease is difficult because of long and variable incubation period from 
the time of infection to when the symptoms become apparent. Symptoms of 
acute brucellosis include malaise, chills, night sweats, weakness, 
fatigue, and weight loss. Active brucellosis without fever is unusual. 
In chronic brucellosis, intermittent malaise and low-grade fever that 
persists over a period of weeks, months, or years are the most common 
complaints. In the United States, human brucellosis is a reportable 
disease in every state except Nevada (41). 
Cooperative State and Federal Brucellosis Eradication Program has 
been in existence in the United States since 1934. In the 1940's, the 
eradication campaign against bovine brucellosis started with serological 
testing and disposal of reactors which resulted in substantial economic 
losses. This was before the advent of vaccination with the attenuated B. 
abortus strain 19. Currently, control of brucellosis is based on 
isolation and slaughter of animals with the disease, immunization by 
vaccination with strain 19, improved management practices, and control of 
animal movement. Cattle diagnosed as positive must be sold for 
slaughter. Exposed herd(s) must be quarantined until repeated testing 
show the remaining animals are free of infection. A state or federal 
veterinarian works with the rancher until the infection is eliminated. 
Female calves (4-12 mo) are vaccinated with strain 19 in areas of high 
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infection rate. During 1987, 9.1 million calves were vaccinated (41). 
Brucella abortus strain 19 is the official USDA-attenuated Brucella 
vaccinal strain for cattle. It was originally isolated by Buck in 1923 
from the milk of a cow. Initially, strain 19 was dependent upon COg and 
was highly virulent; both characteristics decreased after being stored at 
approximately 25° C on solid media for over one year (47). Also, strain 
19 lost its ability to grow on media containing thionin, erythritol, or 
penicillin. Inhibition by erythritol is due to lack of an NAD-dependent 
D-erythrulose 1-phosphate dehydrogenase essential for erythritol 
catabolism (93, 94), Despite changes of biochemical characteristics, the 
antigenic properties of strain 19 were retained, thus providing a means 
for cattle immunizations (95). 
An ideal vaccine has 1) inununogenesis of long duration, 2) minimum 
interference with diagnostic tests, 3) easy production with long 
stability and easy storage, and 4) a minimum of adverse effects in 
vaccinated animals and harmless to humans (74). The current use of the 
attenuated B. abortus strain 19 as a vaccine used in the eradication 
program of bovine brucellosis is limited. Twenty-five to thirty-five 
percent of cattle vaccinated with strain 19 may not establish protective 
immunity (40). This vaccine may cause persistent infections in 
vaccinated cattle (30, 40) or induce 0-polysaccharide-specific antibodies 
that interfere with the interpretation of the standard serodiagnostic 
assays used for detecting Brucella-infected animals (40). The titer is 
virtually indistinguishable from that of natural-infected cattle induced 
by virulent brucellae. Presence of persistent titers following 
vaccination with B. abortus strain 19 complicates the diagnosis. Also, 
the stage of gestation at time of vaccination with B. abortus strain 19 
affects the response of cattle to low-dose strain 19 vaccine (32). 
Infertility and abortion in vaccinated cattle may occur. It would be 
advantageous for a vaccine to elicit an antibody response which is 
clearly distinguishable from that evoked by virulent field stains. In 
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addition, public health concerns are usually associated with the disease 
in cattle since humans may inadvertently become infected when 
administering the vaccine (30, 101, 114). 
Diagnosis 
Determination of brucellosis is best accomplished through the 
interpretation of a battery of tests accompanied with herd and animal 
history. Application of multiple serological assays and bacteriologic 
culture, along with additional pertinent information such as vaccination 
status and herd history, is required for progress to continue towards 
eradication of brucellosis. Diagnosis of bovine brucellosis is commonly 
based on calf mortality, serologic reaction, and isolation of Brucella. 
A precise diagnosis is absolutely dependent upon serological and cultural 
evidence of the disease. An unequivocal diagnosis is made upon 
recovering Brucella organism from the animal. 
Serology. Although protection against brucellosis is primarily 
through the cell mediated immunity (59), most diagnostic assays that are 
currently used rely on detecting a response from the humoral immune 
system (5). Serology helps determine whether the animal is presently 
infected or had previous exposure to antigens of the etiological agent. 
In routine examinations, it is often difficult to isolate Brucella from 
infected cattle. Thus, the disease, brucellosis is usually diagnosed 
serologically. Various serological tests have been developed to identify 
specific antibody responses against Brucella in bovine sera and other 
body fluids. Standard assays used for detecting the presence of 
antibodies against Brucella include the Card, buffered plate antigen, 
complement fixation (definitive test), tube agglutination, and Rivanol. 
Other assays that have been used are passive hemagglutination, counter 
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electrophoresis, radioimmunoassay, Rose Bengal indirect hemolysis test, 
and the ELISA. Complement fixation is reliable and sensitive for 
detecting early and chronic stages of brucellosis (55, 68). The 
development of in vitro assays for cell mediated immunity (e.g., 
lymphocyte blastogenesis assays) are reported (14-16, 98, 99, 113). 
Brucella suis can naturally infect cattle and the serology is 
similar to that of cattle infected with B. abortus. In Florida and 
Texas, there exists the threat of exposure to B. suis from wild feral 
swine. Studies using experimental B. suis-infected cows showed that the 
organism is isolated from milk but not vaginal swabs, blood, and tissues 
(42). No abortion or affect on pregnancy by B. suis has been 
demonstrated. There is no transmittance to other cows, calves, or bulls; 
therefore, cattle are considered a secondary or dead-end host for B. 
suis. 
Isolation. Parturition is the best time for collecting specimens 
for isolating pathogenic strains of B. abortus and, thus, confirm 
brucellosis (32). Occasionally, Brucella will be isolated from cattle 
that are serologically negative, thereby infection is diagnosed by 
bacteriological results alone (77, 104). Shedding of B. abortus via the 
mammary gland may be intermittent (69). Specimens should be cultured as 
soon as possible for maximal sensitivity of bacteriologic culture of 
Brucella. In gravid cows, lymph nodes, spleen, mammary gland, uterus, 
placenta, fetal tissues, and body fluids are commonly used for isolation 
of brucellae (31, 44). 
The growth rate of brucellae is slow especially on primary 
isolation and contaminant bacteria may inhibit growth of the Brucella 
organism. Propagation of colonies on enriched agar media requires 3 to 5 
days, with maximum colony size at 5 to 7 days. Success for isolation of 
the Brucella organism from contaminated sources may be enhanced by using 
yolk sac inoculation of chicken embryos, nasal instillation of mice. 
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intraperitoneal inoculation of guinea pigs, and inoculation of tissue 
cell cultures containing antibiotics. The addition of antibiotics (e.g., 
streptomycin, vancomycin, gentamicin, mycostatin) to artificial media has 
become routine for suppressing growth of contaminating bacteria from 
heavily contaminated specimens. Broad spectrum antibiotics such as 
tetracycline, penicillin, or macrolides must be excluded since they will 
inhibit the growth of brucellae. 
Brucellae 
Taxonomy• Brucellae are Gram-negative, non-motile, non-
sporeforming, aerobic, small (0.5 to 0.7 /im by 0.6 to 1.5 /xm) 
coccobacilli (27). They have a narrow optimum temperature range of 35-39° 
C and pH range of 6.6-7.4 for growth. Respiration is aerobic with a 
cytochrome-based electron transport system. Brucellae have a mole per 
cent of guanine + cytosine (G+C) of 59 (27) and its genome (double 
stranded) is approximately 3,130 kb in size (3). For comparison, the 
genome size of Mycoplasma is approximately 900-1200 kb and E. coli is 
approximately 4700 kb (82, 90). 
Phylogenetic relationships obtained from phenotypic markers have 
been derived by comparing the most environmentally demanding member with 
the less demanding. Phenotypic properties are thought to represent 
stable phylogenic differences. However, the genus Brucella is not a 
member of the family Alcaligenaceae which contains the phenotypically 
related genus Bordetella and Alcaligenes. Instead, genomic studies 
indicate similarity with Agrobacterium and Rhizobium, both of which are 
plant pathogens (39). This relatedness is based on high homology of the 
nucleotide sequence of the 16S rRNA. 
Brucellae are relatively homogeneous in terms of DNA-DNA homology 
(35, 50, 51) and of protein profiles (70). Several molecular genetic 
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studies suggests that the genus Brucella should comprise a single species 
(2, 50, 51, 109). The proposal for one species in the genus would refer 
to the current species as biovars, e. g., B. melitensis biovar abortus. 
This tjrpe of nomenclature would be very misleading. 
The genus Brucella is currently classified into six species which 
closely correlates with their preferred natural hosts and pathogenic 
properties (27, 96). Host specificity may be a relation to precursors 
needed for macrosjmthetic machinery. Occasionally, other hosts become 
infected but Brucella doesn't perpetuate indefinitely in non-reservoir, 
nonpreferential hosts. The six recognized species include B. abortus, 
B. melitensis, B. suis, B. ovis, B. canis, and B. neotomae. The first 
three species are important in terms of worldwide prevalence and 
production of morbidity in domestic animals as well as in humans. 
Brucella abortus, B. melitensis, and B. suis are subdivided into biovars 
on the basis of cultural, biochemical, serological, or metabolic 
characteristics. Biovars of B. melitensis are separated solely on the 
basis of the serological specificity of the surface antigens, A and M; in 
essence, serovars rather than biovars. These antigens (A and M) are 
important determinants in the taxonomy of brucellae. 
Brucella has been Isolated from an aborted fetus of a bottlenose 
dolphin (Tursiops trxmcatus) which may represent a new species of 
Brucella (43). The authors used several approaches including analysis of 
biochemical and oxidative metabolism profiles, protein profiles, and 
virulence in guinea pigs. The bacterial isolate was reported as 
belonging in the genus Brucella, but not matching any known species. 
Biotvnine. Conventional biotjrping tests do not always allow for 
safe identification of biotjrpes and are best suited for reference 
laboratories. There is a need for more objective and widely usable tests 
to better delineate taxa within the single Brucella species and to 
provide a basis for identification of individual strains. Typing 
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isolates of Brucella is done using conventional procedures for 
determination of morphology, cultural characteristics, CO2 requirement, 
H2S and urease production, sensitivity to inhibition by dyes (thionin and 
basic fuchsin), agglutination with specific antisera (A, M, and R 
antigens), susceptibility to antibiotics, and lysis by Brucella 
bacteriophages (4). Oxidative metabolic tests and phage lysis patterns 
are done for species identification. At3rpical strains exist and these 
are usually identified as fitting a certain Brucella species biotype 
except for the stated differences. 
Brucella have oxidative rather than fermentative metabolism. 
Species are separated on the basis of lysis by phage and oxidative 
profiles on selective amino acid and carbohydrate substrates. Brucella 
bacteriophages have been described (29). These characteristics closely 
correlate with the preferred natural hosts of the species. Different 
biochemical techniques are used to distinguish the different species and 
biotypes of Brucella. 
There are three biovars in B. melitensis, five in B. suis, and nine 
in B. abortus; however, there are no reported biotypes in B. ovis, B. 
canis, or B. neotomae. This suggests that B. abortus is genetically more 
labile with respect to biotyping based on phenotjrpic characteristics or 
traits. The determination of biovar is useful in epidemiological 
investigations (5). In cattle, biovars 1, 2, and 4 of S. abortus are 
predominant in the continental United States. In Europe, the most 
frequent B. abortus biovars isolated from cattle are 1 and 3. 
Strains of B. abortus are grouped into nine biovars, however, there 
is no known representative isolate of biovar 8 and biovar 7 was found to 
be a mixture of biovars 3 and 5 (5). All biovars of B. abortus have the 
same general pattern of oxidative metabolism of amino acid and 
monosaccharide substrates (64, 108). Criteria used in biotjrping of B. 
abortus include: COj requirement for growth, H2S production, aniline dye 
sensitivity, and reaction with antisera to A and M antigens (28). Dye 
15 
sensitivity depicts just a single phenotypic characteristic, but it does 
constitutes the basis for the difference of some B. abortus biovars (5, 
27, 96). 
Strain variation in B. ovis is probably not a problem in B. ovis 
control schemes that utilize vaccination or eradication based on serology 
(8). No detectable differences in restriction endonuclease (RE) patterns 
of DNA from B. ovis strains has been reported (8, 76). The species is 
very homogeneous based on RE analysis of B. ovis isolates. Also, no 
biovars have been recognized by other bacteriologists (27). The isolates 
that were examined in RE analysis were from Australia and New Zealand (8, 
76). 
Brucella ovis and B. neotomae are questionable human pathogens 
since no disease in htimans has been attributed to them. Brucella ovis 
causes primarily epididymitis in rams (19). Brucella neotomae has only 
been isolated from desert wood rats in contrast to the widespread 
distribution of the other Brucella species (100). Brucella canis causes 
abortion in dogs (21) and has been reported to infect humans. These 
three species are classified on the justification of lysis by 
bacteriophage, resistance to antibiotics, toxotype, pathotjrpe, and 
serotype. 
Oxidative metabolism. Identification of an isolate of Brucella to 
the species level may depend upon the additional use of the Warburg 
respirometer to determine oxidative rates (65). This apparatus measures 
the ability of a Brucella isolate to metabolize amino acid and 
carbohydrate substrates by volumetric measurements of oxygen consumption. 
Three levels of utilization for Brucella species have been reported 
(108). The first level uses three substrates, L-glutamic acid, L-
alanine, and L-asparagine, which are always utilized by B. abortus and B. 
melitensis. The next level, uses the substrates, L-arginine and DL-
ornithine, which are amino acids from the urea cycle and are usually 
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utilized by B. suis but not by B. abortus or B. melitensis. Utilization 
of the carbohydrate substrates vary from species to species. Profiles 
produced from B. ovls, B. canis, and B. neotomae differ from each other, 
and from the other three species (B. abortus, B. melitensis, B. suis). 
The oxidative metabolic profile for strain 19 has been determined 
(17). The oxidative rate of L-alanine was approximately double of D-
alanine, the rate of L-glutamic acid was invariably greater than 500, and 
oxidative rates of d^ '^ '-galactose and D-ribose were similar. When used 
collectively, strain 19 can be identified, therefore, the oxidative 
metabolic profiles can be used as additional criteria for the 
identification of isolates as strain 19. 
Dissociation. Brucella cultures tend to dissociate during growth 
in laboratory media and after repeated transfers. Subculture of 
brucellae on artificial media lowers virulence which is attributed to 
mutations (mutation rate). The degree of "smoothness" is determined by 
colonial morphology, agglutination in acriflavine, staining with crystal 
violet, agglutination with specific antiserum, autoagglutination in 
saline, or lysis by bacteriophages (4, 5, 61). By obliquely reflected 
light, smooth colonies are round, glistening, blue to blue-green in 
color; rough colonies are dry, granular, yellow to yellow-white in color. 
Colonies (2-3 mm in size) are non-pigmented and non-hemolytic on bovine 
blood agar after 2-3 days incubation at 37° C. 
Comparison between smooth and rough strains of Brucella suggest 
that surface components are involved in the pathogenesis of disease. 
Sjmthesis or secretion of virulence determinants can be affected by 
growth conditions. Repeated transfers induces dissociation and this may 
also select for mutations, selection of variants, or contamination. The 
presence of essential nutrients or cofactors at growth limiting 
concentrations affect the growth of the microorganism. The outcome of an 
infection is determined by the interaction of virulence factors with the 
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surrounding environment. 
The biochemical or genetic mechanism(s) responsible for 
dissociation in Brucella has not been described. Phase variation or 
phenotypic expression of the smooth or rough colonial form is possibly 
due to the altered lipopolysaccharide (LPS) component of the bacterial 
cell wall. The presence of LPS induces the stimulation of 0-antigen 
antibody production during infection. This antibody is transient and 
mechanism of this is not known. 
Surface components (52) and outer membrane proteins (OMPs) (110) of 
B. abortus include major antigens of interest because these bacterial 
components are the most accessible antigens on a live bacterium from the 
viewpoint of antibody binding in the immune host. Antigenic determinants 
associated with the outer membrane play a significant role in the immune 
response since they are involved in the initial interactions between host 
and parasite. Schurig, et al. (87) suggest that immunogens located on 
the surface of the invading microorganism may be more important than 
internal antigens in modulating host's immune response against Brucella. 
For example, the 0-polysaccharide of the LPS molecule is immunodominant 
when compared to other antigens of the Brucella cell. Antibody 
production against 0-chain carbohydrate moieties may be enhanced through 
cytokines (e.g., interleukin 2) produced by T helper lymphocytes 
responding to epitopes on OMPs that are noncovalently associated with LPS 
perhaps in a fashion analogous to that of haptenated proteins in carrier 
protein-hapten systems. 
Ultrastructure. Electron microscopy has proved to be valuable for 
examining ultrastruetural characteristics of bacteria. Specialized 
electron microscopic techniques are necessary for demonstration of 
bacterial surface morphology. For example, methods of Brenner and Home 
(12) are routinely used for staining bacteria in transmission electron 
microscopy for demonstration of surface characteristics. The bacterial 
18 
suspension is stained with neutralized phosphotungstic acid, applied to 
carbon coated grids, and examined using the electron microscope. Outer 
membranes of B. abortus, B. suis, and B. melitensis have typical Gram-
negative cell wall morphology as determined by electron microscopy (75). 
The bacterial cell has an electron-dense nuclear material, ribosomes, and 
a rigid trilaminar cell wall. 
Localization of antigens (e. g., LPS, OMPs, capsule) using an 
anatomical approach distinguishes surface from internal antigens and also 
ascertains possible association with structure and/or function. 
Immunoelectron microscopy techniques probe the organism for 
ultrastruetural location of specific macromolecules. Colloidal gold 
bound to either antibodies, staphylococcal protein A, enzymes, plant 
lectins, toxins, or lipoproteins makes a particularly useful cytochemical 
reagent (85). 
A panel of monoclonal antibodies to seven Brucella OMPs have been 
recently characterized using immunogold labeling for electron microscopy 
(25). Surface exposure of these OMPs were determined using the 
monoclonal antibodies on rough strains, but not all of these monoclonal 
antibodies would bind to smooth strains. This report indicated that the 
long LPS O-side chains causes stearic hindrance in the accessibility of 
some OMPs on smooth Brucella strains. 
Virulence. Pathogenicity seems to correlate with the smooth tjrpe 
of B. abortus. Virulence of different strains of B. abortus is more 
variable within a biovar than between the biovars. For example strain 
19, is smooth but has low virulence as compared to strain 2308 which is 
the USDA standard challenge strain. Yet, both are B. abortus biovar 1. 
Smooth brucellae are ingested less rapidly by macrophages and 
neutrophils than rough brucellae, but do not kill the host cell and 
subsequently multiply partially protected in the phagolysosome (84). 
Rough strains are readily phagocytized, whereas, smooth strains are not 
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(53). Strain 2308 replicates within bovine mammary gland macrophages, 
whereas the numbers of the rough B. abortus strain 45/20 are reduced 
(48). Strain 2308 replicated despite the stimulation of an oxidative 
burst while within the phagosome or phagolysosome. Smooth Brucella 
strains multiply in guinea pig peritoneal macrophages; rough strains do 
not (11). Rough strains bind IgG & other serum proteins nonspecifically, 
whereas smooth don't. Neither rough or smooth strains stimulate hexose-
monophosphate shunt upon ingestion. The T helper cells stimulated by 
specific proteins liberate helper factors which enhance B cell responses 
to these proteins resulting in augmented antibody production against 
these proteins (14-16). 
Facultative intracellular bacteria have developed mechanisms to 
avoid intracellular destruction by resisting lysosomal enzjnraatic assault, 
inhibiting phago-lysosomal fusion, or by escaping to the cytoplasm. 
Brucella abortus LPS does not activate the alternative pathway of human 
complement, thus reducing opsonification by complement and subsequent 
phagocytosis (49). Inhibition of neutrophil degranulation has been 
suggested as a major escape mechanism for 2308 (10). Strain 2308 
releases 5'-guanosine monophosphate and adenine that contribute to the 
intracellular survival by inhibiting the myeloperoxidase-H202-halide 
antibacterial system of bovine neutrophils by inhibiting degranulation 
(20). Strain 45/0 (smooth-intermediate) is more resistant than rough 
strain 45/20 to brucellacidal activity of granule extracts from human and 
bovine neutrophils (57). 
Exotoxins and tissue damaging enzymes have not been reported. 
Lipopolysaccharide (LPS) or endotoxin has been implicated in the 
pathogenesis of brucellosis (1, 66). The LPS determinants are tightly 
associated with protein. The A and M antigens are present on the LPS-
protein complex. Smooth strains of Brucella have both phenol- and water-
soluble LPS when extracted by aqueous phenol. The LPS of the phenolic 
phase shows toxicity in mice. In contrast, rough strains do not have 
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phenol-soluble LPS, but their LPS must be extracted using phenol-
chloroform- ether extraction procedure. 
The LPS is a virulence factor in Brucella infections. 
Lipopolysaccharide extracted from smooth strain 45/0 suppresses ^ H-
thymidine incorporation by spleen cells of mice, whereas LPS extracted 
from the rough, avirulent, genetically related strain 45/20 was much less 
suppressive (58). LPS is stable to heat and resists pronase digestion. 
The LPS is the immunodominant antigen of Brucella (74). 
Circulating antibody is made in response primarily to the polysaccharide 
determinants of the cell wall LPS in animals infected with smooth 
Brucella and not to the protein component, while animals immunized with 
rough strains of Brucella have antibodies only to protein antigens (54). 
The 0 chains of LPS from smooth Brucella have common antigens or similar 
epitopes with Yersinia enterocolitica 0:9, Francisella tularensis, 
Escherichia coli, and Vibrio cholerae (26). 
Brucella in bison and elk 
Over the last decade, public trends and concerns about the 
environment have intensified. Elevated numbers of bison {Bison bison) 
and elk (Ceirvus elaphus) in wild and domestic herds have increased the 
concern about their susceptibility to bovine brucellosis and the 
potential for bison and elk as reservoirs or carriers of this disease. 
Brucellosis is prevalent in some bison herds (60) and Brucella-infected 
bison are capable of transmitting the organism to cattle (34, 45). Bison 
and elk have been reported as significant reservoirs of B. abortus (67, 
83, 103, 105, 111). 
In North America, the primary problem in brucellosis is the 
persistence of B. abortus in certain regions. National eradication 
programs were established in USA and Canada to reduce economic losses for 
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livestock industries and to reduce the risk of Brucella exposure to 
hvimans. However, brucellosis in wild ungulates threatens the eradication 
progress of bovine brucellosis. Brucellosis is significant because of 
its zoonotic nature and its potentially devastating effects on both free-
ranging and captive ungulates, as well as on the livestock industry. 
There is persistent B. abortus infection in free-ranging elk herds 
of Wyoming's National Elk Refuge, Yellowstone National Park, and Grand 
Teton Nation Park in the United States. One study demonstrated up to 50% 
prevalence of infection in elk (106). Brucellosis would jeopardize any 
attempt to raise cattle on ranges surrounding areas such as these. 
The presence of B. abortus in free-ranging bison and elk 
populations has led to land use and animal conflicts. Current management 
and public relations controversies include brucellosis in the bison and 
elk of the Greater Yellowstone Area (GYA), USA. The GYA encompasses 
Yellowstone National Park, Grand Teton National Park, and thousands of 
acres surrounding public and private lands. The high number of Brucella 
isolates in GYA reflects an area of enzootic bison and elk brucellosis or 
the intensive sample collection effort in this area. Continued testing 
of bison and elk in these areas and intensified testing of the bison and 
elk in other areas are needed to better define the distribution of the 
disease. Interpretations of serological reactions in brucellosis testing 
in wildlife is unclear due to the possibility of false positive, false 
negative, and cross reactions from other Gram-negative bacteria. 
Experimental infections of B. abortus and serologic testing in bison and 
elk are needed to clarify the disease status in free-ranging bison and 
elk. 
Control of brucellosis depends on the ability to identify and 
remove Brucella-infected animals and on prophylactic measures such as 
vaccination. Therefore, a need exists for a useful epidemiological 
marker(s) for tracking Brucella organism in region where brucellosis 
occurs in an outbreak from wild animal reservoir or cattle import. 
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Pulsed field electrophoresis 
Introduction of pulsed-field gel electrophoresis (PFGE) of DNA has 
provided the means for separating DNA fragments in the 25 kilobase pairs 
(kb) to megabase range. This technique was first described by Schwartz 
and Cantor of Columbia University in 1984 (89). Resolution of fragments 
by conventional electrophoresis depends on the sieving characteristics of 
the gel which is only effective for fragments less than 30 kb. Larger 
fragments migrate collectively and appear as a diffuse band. The 
direction of migrating DNA is periodically altered by changing the 
electric field angle through the gel, as in PFGE. Fragments from this 
diffuse band separate from each other when PFGE is applied. Smaller 
fragments reorientate and move with the direction of the electric field 
more quickly than larger molecules. The larger DNA fragment lags behind 
giving separation from the smaller fragments. 
Optimal PFGE separations of DNA fragments depend on numerous 
factors. These include fragment size, switch time, switch-time ramp, 
voltage gradient, run time, pulse angle, buffer type and concentration, 
and temperature. Pulse-field switch time, or simply switch time, is 
defined as the duration of a pulse in one direction. For a given field 
strength and temperature, longer pulses resolve larger fragments of DNA. 
A constant pulse time separation provides the best separation for a given 
size range. 
Genomic DNA fingerprinting has been successful as a method of 
species and strain identification applicable for bacterial pathogens 
(80). Genomic diversity between strains is detected by direct 
visualization of stained fragments that are produced by digesting total 
DNA with a suitable restriction endonuclease, followed by electrophoresis 
in agarose or acrylamide gels or by PFGE. Each procedure separates the 
digested fragments of a distinct size range. The restriction enzyme 
should cleave the DNA into a moderate ntimber (10 to 25) of well-resolved 
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fragments within the selected size range for the electrophoresis method. 
Ethidium bromide stained DNA fluoresces when exposed to medixm wave 
ultraviolet light whose predominant emission is centered around 312 nm. 
Photographs are taken for documentation, identification, and qualitative 
analyses. DNA fragments may be transferred to nylon or nitrocellulose 
membrane by procedure called "Southern blotting" (92). Transfer is done 
electrophoretically or by capillary action. Following blotting, the DNA 
fragments are hybridized by labelled DNA strands called probes that act 
by complementary base pairing. Other applications include chromosome and 
RFLP analysis, gene or genome mapping, library screening, and analysis of 
population samples, and to separate mixtures of nucleic acid molecules. 
Restriction fragment length polymorphisms in genetic material (DNA) cut 
with restriction endonucleases have provided definitive "fingerprinting" 
by detecting specific changes in gene location on the genome. Brucella 
strains have been differentiated by using PGR with conventional gel 
electrophoresis that locate specific DNA fragments (13). 
The DNA polymorphisms in Brucella species and physical mapping of 
B. melitensis strain 16M genome using PFGE with low-cleavage-frequency RE 
have been reported (2, 3). Different electrophoretic banding patterns of 
genomic digests were identified for each type strain of B. abortus, B. 
melitensis, B. suis, B. ovis, and B. canis (B. neotomae was not 
examined); profile differences among many of the biovars within a species 
were documented (2). Allardet-Servent et al. (2) reported that B. 
abortus biotypes 1, 2, 3, and 4 differed but biotypes 5, 6, 9 of B. 
abortus had fingerprints identical to that of biotype 4. The distinction 
between Brucella species by use of PFGE correlated with the preferred 
natural host specificity, growth characteristics, and serologic, and 
bacteriologic methods used for classifying Brucella species. 
Restriction endonuclease analysis. Restriction endonucleases (RE) 
are enzjnnes which cleave DNA at specific sites, usually defined by a 4, 
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6, or 8 base pair sequence on the DNA. For example, Xbal cuts DNA 
wherever the sequence 5'-TCTAGA-3' occurs. A point mutation at any base 
within the recognition sequence results in the RE no longer capable of 
cleaving the DNA at this site. These mutations occur at low frequency 
during replication since many would have no selective advantage or 
disadvantage and would propagate stability. The more G+C in the DNA, the 
less frequency of the cutting. Also, the longer the recognition site is, 
the lower the frequency of cutting is. 
Due to enormous number of base pairs in the genome, extracted DNA 
from the cell is broken into smaller pieces at specific sites with RE. 
This causes the double helical structure of DNA to split. The DNA 
fragments of different sizes are then separated by gel electrophoresis 
which applies an external electric field to the gel containing the DNA 
resulting in the mobility of DNA through the gel. The distance of 
migration for the various fragments is dependent on the size of the DNA. 
High frequency cutting RE reveal very little differences between 
the strains of Brucella due to the high niomber of generated fragments for 
electrophoretic patterns to be easily distinguishable (8, 76), The RE, 
Tthlll I and Xba I, did not cut Brucella DNA according to O'Hara (76). 
He also observed that Bam HI, BstE II, Kpn I, Sac I, and Sma I, and Xho I 
gave incomplete digestion because of broad bands of very high molecular 
weight in the conventional gel electrophoresis. The REs, Bgl I, Hind 
III, and EcoR I completely digested Brucella DNA into many small 
fragments. 
Fragments of DNA, greater than 100 kb, require careful handling 
since they are very susceptible to shearing. In general, cells are 
imbedded in agarose and then exposed to cell lysis reagents and enzymes 
which disrupt cell walls and digest membranes and proteins. Cellular 
digestion products are then allowed to diffuse out and the resulting 
agarose-embedded DNA is ready for further analysis (e.g., RE analysis). 
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B. abortus strain RB51 
Brucella abortus strain RB51 has been proposed to replace B abortus 
strain 19 for use as a vaccine in cattle against brucellosis (22, 88). 
Strain RB51 was derived from a rifampin-resistant mutant of the virulent 
B. abortus strain 2308 and is much less pathogenic than 2308 (88). 
Brucella abortus 2308 is a smooth, virulent, laboratory-adapted field 
strain that is pathogenic to cattle and is used as the USDA's official 
challenge strain. The rough mutant, RB51, lacks the 0-antigen of 
Brucella lipopolysaccharide (88). 
Cattle vaccinated with RB51 are protected from abortion following 
challenge with virulent smooth B. abortus strain 2308 (24) and have cell-
mediated immune responses against 2308 similar to those of cattle that 
are vaccinated with strain 19 (98). Cattle vaccinated with strain 19 
produce 0-polysaccharide-specific antibodies that impede interpretation 
of the standard serodiagnostic assays for detecting Brucella-infected 
animals (73, 112). In contrast to strain 19, RB51 does not induce 
antibodies in serum that will interfere in the standard serology used for 
detecting naturally acquired brucellosis. 
Antibodies against the 0-chain of Brucella lipopolysaccharide have 
not been detected by use of the standard tube agglutination test or by 
immunoblotting with sera from RB51-immunized cattle, goats, rabbits, or 
mice (22, 88). When testing sera of RB51-vaccinated cattle, the standard 
tube agglutination assay does not detect antibodies produced against the 
0-polysaccharide of Brucella lipopolysaccharide (22, 24, 88, 97). The 
card, complement fixation, and particle concentration fluorescence tests 
are also negative (97). Unlike strain 19-vaccinated cattle, cattle 
vaccinated with RB51 fail to develop cutaneous reactions to brucellin 
that are thought to be induced by LPS (23). 
Survival of the vaccine strain is crucial for cattle to develop a 
protective cellular immune response against Brucella (22). Strain RB51 
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persists for several weeks in superficial cervical lymph nodes of cows 
that have been vaccinated with RB51. In mice, the organism is cleared by 
four weeks post inoculation (PI) (88) . Strain RB51 maintains rough 
characteristics after 15 passages in mice (in vivo) at two weeks PI per 
mouse (88), after experimental infection in goats with no abortion (86), 
and even after 93 passages in vitro (88). 
Changes in colonial morphology (i.e., smooth to rough) are 
associated with changes in infectivity and antigenicity (5). Smooth 
strains of Brucella have lipopolysaccharide (LPS) or endotoxin which has 
been implicated in the pathogenesis of brucellosis (1, 66). Strain RB51 
has rough colonial morphology and lacks the 0-polysaccharide of smooth 
LPS (88). Reversion to smooth colonial morphology and virulence for the 
rough B. abortus strain 45/20 has been reported (62, 102), but not for 
RB51. 
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APPLICATION OF PULSED-FIELD GEL ELECTROPHORESIS FOR 
DIFFERENTIATION OF VACCINE STRAIN RB51 FROM FIELD ISOLATES OF 
BRUCELLA ABOSTUS FROM CATTLE, BISON, AND ELK 
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Abstract 
Restriction endonuclease patterns of genomic fragments separated by 
use of pulsed-field gel electrophoresis were used to differentiate 
Brucella abortus strain RB51, a rifampin-resistant mutant of the standard 
virulent strain 2308, from other brucellae. Results were compared with 
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Electrophoretic patterns of the ATCC tjrpe strains allowed identification 
 ^No endorsements are herein implied. Brand names are necessary to report 
factually on available data; however, the USDA neither guarantees nor 
warrants the standards of the products, and the use of the names by USDA 
implies no approval of the products to the exclusion of others that may also 
be suitable. 
 ^Vol. 56, no. 3, pages 308-312, March 1995. 
 ^Brucellosis Research Unit, National Animal Disease Center, Agricultural 
Research Service, USDA, Ames, lA 50010. 
* Corresponding author. 
 ^Diagnostic Bacteriology Laboratory, Animal and Plant Health Inspection 
Service, USDA, Ames, lA 50010. 
® Department of Microbiology, Immunology, and Preventative Medicine, College 
of Veterinary Medicine, Iowa State University, Ames, lA 50011. 
28 
of the strains to the level of species. Genomic profiles of B abortus 
biovars 1, 2, and 4 were similar, as were those of biovars 5, 6, and 9. 
The profile of biovar 3 was similar to that of biovars 5, 6, and 9, 
except for a missing band at 93 kb and additional bands at 65 and 67 kb. 
A different fingerprint was detected in B abortus strain RB51, using the 
pulsed-field gel electrophoresis patterns of genomic DNA digested with 
restrictive endonuclease Xba I. The profile of B abortus strain RB51 
contained a band at 104 kb, as opposed to a 109-kb fragment within 
profiles of B abortus isolates from naturally infected cattle, bison, and 
elk. Despite known biochemical and biological differences between RB51 
and its parent strain (2308), restriction endonuclease analyses were 
similar. 
Introduction 
Brucella abortus strain RB51 has been proposed to replace B abortus 
strain 19 for use as a vaccine in cattle against brucellosis (4, 13). 
Cattle vaccinated with strain 19 produce 0-polysaccharide-specific 
antibodies that impede interpretation of the standard serodiagnostic 
assays for detecting Brucella-infected animals (10, 18). Strain RB51 is 
a stable rough mutant of virulent B abortus strain 2308 and lacks 
lipopolysaccharide 0-side chain (13). Antibodies against the 0-chain of 
brucella lipopolysaccharide have not been detected by use of the standard 
tube agglutination test or by immunoblotting with sera from RB51-
immunized cattle, goats, rabbits, or mice (4, 13). 
Standard restriction endonuclease (RE) analysis of Brucella DNA, 
using high-cleavage-frequency RE (ie, Hind III) indicated no differences 
in DNA fragment patterns (less than 23.1 kb) among strains of B ovis and 
only minor differences among B abortus, B melitensis, B canis, and B ovis 
strains (11). The DNA polymorphisms in Brucella species and the physical 
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mapping of B melitensis strain 1611 genome using pulsed-field gel 
electrophoresis (PFGE) with low-cleavage-frequency RE (eg, Xba I) have 
been reported (1, 2). Pulsed-field gel electrophoresis separates DNA 
fragments more than 25 kb to several megabase pairs in size (14). 
Different electrophoretic banding patterns of Xba I genomic digests were 
identified for each type strain of B abortus, B melitensis, B suis, B 
ovis, and B canis; profile differences among many of the biovars within a 
species were documented (1). 
The objective of the study reported here was to determine whether 
PFGE could be used to differentiate B abortus strain RB51 from other 
Brucella strains and species. Although our focus was principally on B 
abortus isolated from cattle, we also examined vaccinal, wildlife, and 
type strains, as well as genetically-engineered brucellae. 
Materials and methods 
Brucellae and DNA preparation. Brucella isolates (Table 1) were 
biotyped by use of described methods (3), and were grown for 24 hours at 
37 C on Brucella agar (GIBCO Laboratories, Grand Island, NY). 
Preparation of high molecular weight genomic DNA from the isolates of 
Brucella (Table 1) was done by modifications of a published procedure 
(9). Cells were suspended in TE buffer (10 mW Tris HCl [pH, 8], 1 mW 
EDTA), centrifuged (10,000 x g for 10 minutes at 5 C), resuspended in TE 
buffer to 5 X 10® colony-forming units/ml, and stored at -20 C tintil 
needed. Cells were thawed, mixed in equal voltjunes of low-melt agarose 
(1%; Bio-Rad Laboratories, Richmond, CA), and dispensed in a slot former. 
Inserts were incubated at 37 C for 48 hours in 0.5 M EDTA with 1% (w/v) 
soditim dodecyl sulfate (SDS) and 1 mg of pronase (Calbiochem, La Jolla, 
CA)/ml. Protein digestion products were removed by washing inserts. 
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using TE plus 1 wM phenylmethylsulfonyl fluoride. The DNA preparations 
in agarose were stored in 0.05 M EDTA (pH, 8.0) at 4 C. 
Restriction endonuclease digestion and electrophoresis. Brucella 
genomes were digested with Xba I (GIBCO BRL Life Technologies Inc, 
Gaithersburg, MD) as described (1). Digest fragments were separated, 
using PFGE (14) and the clamped homogeneous electric fields system (CHEF-
DRII, Bio-Rad Laboratories, Richmond, CA). Gels were run in TBE buffer 
(0.045 M Tris, 0.045 M boric acid, 0.001 M EDTA) for 42 hours at 200 V 
with ramp-switch time of 5 to 10 seconds. The DNA was stained with 
ethidivun bromide, transilluminated with UV light, and photographed. Size 
of fragments in photographs was determined, using a computer-assisted 
analysis program (Biolmage Products, Millipore Corporation, Ann Arbor, 
MI) with lambda ladder PFGE marker (New England Biolabs, Beverly, MA). 
Results 
The PFGE analysis of Brucella DNA digested with Xba I revealed 
species differences in genomic fingerprints. Restriction patterns of 
digests consisted of approximately 25 to 35 fragments in the size range 
of about 25 to 350 kb for each Brucella species. Unique electrophoretic 
differences were discernible among B abortus, B melitensis, B suis, B 
ovis, B canis, and B neotomae strains (FIG. lA). In contrast, profiles 
of B abortus reference biovars (FIG. IB) were related; differences were 
observed in regions at 128 and C 193 kb. Profiles of biovars 1, 2, and 4 
(FIG. IB, lanes 2, 3, and 5) were similar, as were those of biovars 5, 6, 
and 9 (FIG. IB, lanes 6-8). The profile of biovar 3 (FIG. IB, lane 4) 
was similar to that of biovars 5, 6, and 9 (FIG. IB, lanes 6-8); this 
profile lacked a band at 93 kb and contained additional bands at 65 and 
67 kb. The fingerprint of B abortus strain RB51 (FIG. IB, lane 1) 
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contained a 104-kb fragment, and profiles of B abortus reference biovars 
(FIG. IB, lanes 2-8) contained a fragment at 109 kb. 
The PFGE of Xba I digests of DNA from B abortus IIB51 were different 
from isolates identified as B abortus biovar 1, biovar 2, biovar 4, and B 
suis biovar 1 that had been obtained from cattle (FIG. 2). Strain EIB51 
could be separated from these isolates on the basis of the 104-kb 
fragment. Brucellae isolated from draining lymph nodes of cattle at 14 
days after RB51 vaccination contained the band at 104 kb, similar to B 
abortus strain RB51 (FIG. 2A, lanes 1 and 10). Brucella suis isolated 
from cattle (FIG. 2D, lane 3) had the same Xba I digest pattern as B suis 
isolated from swine (FIG. lA, lane 4). 
The Brucella isolates from bison and elk were identified as B 
abortus biovar 1. These isolates had similar Xba I digest patterns, as 
did B abortus biovar 1 isolates from cattle. Strain RB51 could be 
separated from these wildlife isolates on the basis of the migrating 104-
kb digest fragment (FIG. 3). 
Brucella strains derived from strain 2308, including strain RB51, 
had similar electrophoretic profiles (FIG. 4A, lanes 3-7), but differed 
from B abortus ty^ pe strain 544 (FIG, 4A, lane 2). Vaccine strain 19 had 
profile similar to that of B abortus biovars 1, 2, and 4. Strain 19 and 
mutants derived from this strain had similar profiles (FIG. 4B, lanes 2-
5) and differed from strain RB51 (FIG. 4B, lane 1). Strains 19, 11, 
1119-3, and 45/20 of B abortus (FIG. 4C) which have been used as vaccines 
or for antigen production (ie, strain 1119-3) had patterns similar to 
those of the field strains. Interestingly, strain 11 (FIG. 4C, lane 2) 
did not have the 165-kb band, which was present in other B abortus 
isolates, but had 2 additional bands at 94 and 68 kb. 
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Discussion 
Pulsed-field gel electrophoresis of Xba I digests of DNA from 
brucellae produced a distribution of DNA fragments useful for comparing 
strains of B abortus. A unique restriction endonuclease pattern was 
detected in B abortus biovars that would be useful for characterization 
of B abortus strain RB51. This fingerprint separated strain K£51 from 
Brucella isolates obtained from cattle, wildlife, tjrpe strains, vaccine 
strain 19, and genetically-engineered strain 19. Restriction fragment 
length polymorphism analysis (RFLP) would enhance discrimination of the 
vaccine candidate RB51 from field strains of Brucella. 
Development of rapid DNA extraction procedures, genetic probes, and 
computer-assisted analyses programs have increased the level of 
discrimination in RFLP analysis among closely related strains. Use of 
computer-assisted programs proves to be an excellent method to store, 
retrieve, compare, and evaluate RE fragment patterns. A single 
electrophoretic gel can yield easily analyzable data, which can be 
compared with data from other gels. 
The great heterogeneity in RE patterns among the 6 species of 
Brucella is in agreement with a report by Allardet-Servent et al. (1). 
The distinction between Brucella species by use of PFGE correlated with 
the preferred natural host specificity, growth characteristics, and 
serologic, and bacteriologic methods used to classify Brucella species. 
Results of our study indicate that biovars of B abortus do not greatly 
vary in their PFGE fingerprints, and this is suggestive of an 
evolutionary convergence of this species. All biovars of B abortus have 
the same general pattern of oxidative metabolism of amino acids and 
monosaccharides substrates (8). It is reasonable to assume that as long 
as environmental factors (ie, natural host) are stable, the phenotype 
continues (17). Although several bands were common (ie, migrated same 
relative distance) in the genomic fingerprints, there were differences 
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among restriction profiles of the Brucella type strains and B abortus 
reference biovars. ¥e do not know the basis for pattern differences; 
however, restriction sites (redistribution) may be attributable to 
mutations affecting the restriction sites or by appreciable genomic 
rearrangements, such as translocations, inversions, or distribution of 
repetitive elements (6,12), rather than to large deletions or insertions, 
as indicated by the strong DNA-DNA homology among Brucella species (16). 
Direct observance of RE digest patterns (fingerprints) of brucellae 
offers a rapid and reproducible method for the characterization and 
classification of isolates applicable to ecological, etiologic, 
epidemiologic, and population genetic studies. The accurate 
identification and discrimination of RB51 from other brucellae are the 
preconditions to assess vaccination success and to prevent further 
dissemination of possible pathogenic brucellae. Strain RB51 and strain 
RB51 isolated from cattle lymph nodes 2 to 4 weeks after vaccination had 
identical RE patterns, suggesting the strain's genetic stability. The 
PFGE method may be used to differentiate among strains and identify a 
strain responsible for an episode of brucellosis and determine whether 
strain RB51 was implicated. The consistency of the profile results 
support the use of PFGE as an identification tool for B abortus. 
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Table 1. Source of Brucella strains 
Oreanism Host Orlein Reference 
B abortus biovar 1 
544 (ATCC23448) Cattle England ATCC* 
RB51 Lab strain US (13)^  
2308 Cattle US NADC*" 
2308R Lab strain US NADC 
2308-SOD Lab strain US (15) 
2308-31 Lab strain US (5) 
45/20 Lab strain England (7) 
11 Cattle US NADC 
1119-3 Lab strain US NADC 
A&M12(10) Bison WY A&M'= 
A&M14(64) Bison WY A&M 
A&M14(65) Bison WY A&M 
A6M15(36) Bison WY AS^  
ASM15(36A) Bison WY A&M 
A&M16(37) Bison WY A&M 
DBL5-805 Bison MT NVSL"^  
DBL5-958 Bison MX NVSL 
DBL5-959 Bison MT NVSL 
DBL5-1057 Bison MT NVSL 
DBL5-1058 Bison MT NVSL 
DBL5-1059 Bison MT NVSL 
DBL8-999 Bison SD NVSL 
DBL9-1657 Bison WY NVSL 
DBL9-1658 Bison WY NVSL 
DBL8-953 Elk US NVSL 
DBL8-954 Elk US NVSL 
DBL8-955 Elk US NVSL 
DBL8-956 Elk US NVSL 
DBL8-957 Elk US NVSL 
DBL2016 Cattle MS NVSL 
DBL2018 Cattle CA NVSL 
DBL2033 Cattle MO NVSL 
DBL2042 Cattle FL NVSL 
DBL2038 Cattle TN NVSL 
DBL2054 Cattle NM NVSL 
DBL2073 Cattle GA NVSL 
DBL2470 Cattle KY NVSL 
NADC1160 Cattle US NADC 
B abortus strain 19 
19 (ATCC27565) Cattle US ATCC 
19R Lab strain US NADC 
19-SOD Lab strain US (15) 
19-31 Lab strain US (5) 
DBL2050 Cattle CA NVSL 
DBL2052 Cattle OK NVSL 
DBL2032 Cattle MO NVSL 
DBL2472* Cattle CA NVSL 
NADC1161 Cattle US NADC 
B abortus biovar 2 
86/8/59 (ATCC23449) Cattle England ATCC 
DBL2381 Cattle FL NVSL 
DBL2444 Cattle OK NVSL 
B abortus biovar 3 
Tulya (ATCC23450) Human Uganda ATCC 
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Table 1. continued 
B abortus biovar 4 
292 (ATCC23451) Cattle England ATCC 
DBL2064 Cattle MS NVSL 
DBL2194 Cattle LA NVSL 
DBL2376 Cattle FL NVSL 
B abortus biovar 5 
B3196 (ATCC23452) Cattle England ATCC 
B abortus biovar 6 
870 (ATCC23453) Cattle Africa ATCC 
B abortus biovar 9 
C68 (ATCC23455) Cattle England ATCC 
B melitensis biovar 1 
16M (ATCC23456) Goat US ATCC 
B suis biovar 1 
1330 (ATCC23444) Swine US ATCC 
DBL2366 Cattle lA NVSL 
B ovis 
63/290 (ATCC25840) Sheep Africa ATCC 
B canis 
RM-666 (ATCC23365) Dog US ATCC 
B neotomae 
5K33 (ATCC23459) Wood Rat UT ATCC 
* Grew on medium containing erythritol. 
' American Type Culture Collection, Beltsville, MD. 
'' National Animal Disease Center, Ames, lA. 
® Dr. T. Ficht, Texas A & M, College Station, TX. 
Ms. D. Ewalt, National Veterinary Service Laboratories, Ames, lA. 
FIG. 1. Pulsed-field gel electrophoresis (PFGE) of Xba I 
digests of DNA from Brucella abortus RB51, 
Brucella type strains (A), and B. abortus 
reference biovars (B). A—Lanes: 1, B. abortus 
RB51; 2, B. abortus 544; 3, B. melitensis 16M; 4, 
B. suls 1330; 5, B. ovis 63/290; 6, B. canis RM-
6/66; and 7, B. neotomae 5K33. B—Lanes: 1, B. 
abortus RB51; 2, B. abortus 544, biovar 1; 3, B. 
abortus 86/8/59, biovar 2; 4, B. abortus Tulya, 
biovar 3; 5, B. abortus 292, biovar 4; 6, B. 
abortus B3196, biovar 5; 7, B. abortus 870, 
biovar 6; and 8, B. abortus C68, biovar 9. 
Positions of size (kb) markers are indicated. 
339.5^ 
291.0; 
242.5' 
194.0' 
145.5-
97.0-
48.5-
FIG. 2. The PFGE of Xba. I digests of DNA from B. abortus 
RB51 and field isolates from cattle typed as B. 
abortus biovar 1 (A), biovar 2 (B), biovar 4 (G), 
and B. suis (D). A—Lanes: 1, RB51; 2, DBL2016 
(MS); 3, DBL2018 (CA); 4, DBL2033 (MO); 5, 
DBL2042 (FL); 6, DBL2038 (TN); 7, DBL2054 (NM); 
8, DBL2073 (GA); 9, DBL2470 (KY); 10, NADC1160 
(RB51); 11, DBL2050 (CA, strain 19); 12, 2052 
(OK, strain 19); 13, DBL2032 (MO, strain 19); 14, 
DBL2472 (CA, strain 19, erythritol +); and 15, 
NADC1161 (strain 19). B—Lanes: 1, RB51; 2, 
DBL2381 (FL); and 3, DBL2444 (OK). C—Lanes; 1, 
RB51; 2, DBL2064 (MS); 3, DBL2194 (LA); and 4, 
DBL2376 (FL). D—^ Lanes: 1, vaccine strain 19; 2, 
RB51; and 3, B. suis DBL2366 (lA). Region of 104 
or 109 kb fragment (*) is shown in A, B, and C. 
Positions of size (kb) markers are indicated. 
A 
Biovar 1 
2 3 4 5 6 7 8 9 10 11 12 13 14 15 
? ^ 5-r- - 55 ^ - ^ 
• 242.5 
194.0 
I-145.5 
B 
Biovar 2 
1 2 3 
C 
Biovar 4 
12 3 4 
FIG. 3. The PFGE of Xba. I digests of DNA from B. abortus 
isolated from bison (A) and elk (B). A—Lanes: 
1, RB51; 2, A&M12(10; WY); 3, A&M14(64; WY); 4, 
A&M14(65; WY); 5, A&M15(36; WY); 6, A&M15(36A; 
WY); and 7, A&M16(37: WY) . B—Lanes: 1, RB51; 2, 
DBL8-953; 3, DBL8-954; 4, DBL8-955; 5, DBL8-956; 
and 6, DBL8-957. Positions of size (kb) markers 
are indicated. 
291.0 V 
242.5 
194.0' 
145.5 
1 2 
A 
3 4 5 6 7 
97.0 —I 
48.5 — 
FIG. 4. The PFGE of Xba I digests of DNA from B. abortus 
RB51, genetic mutants, and vaccinal strains. 
T3rpe strain and mutants of the challenge strain 
2308 (A), lanes; 1, lambda concatemers; 2, 544; 
3, RB51; 4, 2308; 5, 2308R; 6, 2308-SOD: and 7, 
2308-31K. Mutants strains of vaccine strain 19 
(B), lanes: 1, RB51; 2, 19-SOD; 3, 19-31; 4, 
19R; and 5, 19. Vaccinal strains (C), lanes; 1, 
19; 2, 11; 3. 1119-3; 4, 45/20; and 5, RB51. 
Positions of size (kb) markers are indicated. 
A B C 
1 2 3 4 5  6 7  1 2 3 4 5  1 2 3 4 5  
2415 
194.0 
145.5 
97.0 
48.5 
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DIFFERENTIATION OF BSDCELLA ABOSIUS STRAIN RB51 FROM BSUCEILA ABORTUS 
ISOLATED FROM BISON AND ELK AND DETERMINATION OF STABILITY BY USE OF 
GENOMIC FINGERPRINT, OXIDATIVE METABOLISM, AND COLONIAL MORPHOLOGY 
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Abstract 
Brucella abortus strain RB51 and isolates from cattle, bison, and 
elk were characterized using pulsed-field gel electrophoresis (PFGE) and 
standard techniques for biotyping Brucella which included biochemical, 
morphological, antigenic, phage susceptibility, and antibiotic resistance 
characteristics. The objectives were to differentiate RB51 from other 
brucellae and to ascertain the stability of RB51. Genomic restriction 
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endonuclease patterns produced by PFGE demonstrated a unique fingerprint 
for RB51 relative to other brucellae. Comparisons of oxidative metabolic 
profiles of RB51 after time in vivo (14 weeks) and in vitro (75 passages) 
showed no change in characteristic patterns of oxygen uptake on selected 
amino acid and carbohydrate substrates. Strain RB51 was biotyped as a 
typical rough 3. abortus biovar 1 (not strain 19) after animal passage or 
high passage in vitro and remained resistant to rifampin or penicillin 
and sensitive to tetracycline. No reactions with A or M antisera or with 
monoclonal antibody to 0-antigen of Brucella lipopolysaccharide were 
detected; however, it agglutinated with R antisera. Results indicate 
that the genomic fingerprint and rough colonial morphology of RB51 can be 
used to differentiate this vaccine from smooth isolates of Brucella 
isolated from cattle, bison, and elk examined. 
Introduction 
Brucella abortus strain RB51 has been proposed as a vaccine to 
replace strain 19 which is currently used in the eradication program 
against brucellosis in domestic cattle. Cattle vaccinated with RB51 are 
protected from abortion following challenge with virulent smooth B. 
abortus strain 2308 (9) and have cell-mediated immune responses against 
2308 similar to those of cattle that are vaccinated with strain 19 (35) . 
In contrast to strain 19, RB51 does not induce antibodies in serum that 
react immunologically in tests that are used to detect naturally acquired 
brucellosis. When testing sera of RB51-vaccinated cattle, the standard 
tube agglutination assay does not detect antibodies produced against the 
•-polysaccharide of Brucella lipopolysaccharide (LPS; 7, 9, 32, 34). The 
card, complement fixation, and particle concentration fluorescence tests 
are also negative (34). In addition, unlike strain 19-vaccinated cattle, 
cattle vaccinated with RB51 fail to develop cutaneous reactions to 
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brucellin that are thought to be induced by LPS (8). 
Bacterial survival of the vaccine strain is crucial for cattle to 
develop a protective cellular immune response against Brucella (7). 
Strain RB51 persists for several weeks in superficial cervical lymph 
nodes of cows that have been vaccinated with RB51. In mice, the organism 
is cleared by four weeks post inoculation (PI; 32). Strain RB51 
maintains rough characteristics after 15 passages in mice (in vivo) at 
two weeks PI per mouse (32), after experimental infection in goats with 
no abortion (30), and even after 93 passages in vitro (32). However, the 
capacity of RB51 to remain stable after long periods of time in the host 
is not known; e.g., isolates of RB51 from lymph nodes of RB51-vaccinated 
cattle have not been characterized to determine changes. 
In general, changes in colonial morphology (i.e., smooth to rough) 
are associated with changes in infectivity and antigenicity (4). Smooth 
strains of Brucella have LPS or endotoxin which has been implicated in 
the pathogenesis of brucellosis (1, 21). Strain RB51 has rough colonial 
morphology and lacks the 0-polysaccharide of smooth LPS (32). Reversion 
to smooth colonial morphology and virulence for the rough strain 45/20 
has been reported (18, 36), but not for RB51. 
Several studies have demonstrated differences in genomic DNA 
restriction fragment patterns among Brucella species (2, 16). Recently, 
it was reported that PFGE analysis of Xba I-digested genomic DNA provides 
a reliable means of differentiating B. abortus strain RB51 from field 
isolates of B. abortus biovars 1, 2, and 4 from cattle and several 
isolates of biovar 1 from bison and elk (16). 
Brucella are identified by routine techniques that are used for 
biotyping (4). Conventional tjrping includes dye, penicillin, erythritol, 
and bacteriophage sensitivity patterns, production of hydrogen sulfide, 
relative rates of urea hydrolysis, and reactivity with specific 
antiserum. The accurate identification of an isolate of Brucella to the 
species level may depend upon the additional use of Warburg respirometer 
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to determine oxidative rates (20). This apparatus measures the ability 
of a Brucella isolate to metabolize amino acid and carbohydrate 
substrates by volumetric measurements of oxygen consvimption. 
As the goal of eradication of brucellosis in domestic cattle nears 
completion, the consideration of wildlife as reservoirs of B. abortus 
becomes important. Bison (Bison bison) and elk (Cervus elaphus) are 
significant reservoirs of B. abortus (22, 27, 38, 39, 42); therefore, 
brucellosis would jeopardize any attempt to raise cattle on ranges 
utilized by Brucella-infected bison and elk. Bacteriologic isolation of 
Brucella species from bison and elk sampled from 1985 to 1995 provides 
the opportunity for a retrospective evaluation of the importance and 
differentiation of Brucella in wildlife from the proposed vaccine strain 
RB51. Because of potential impact of brucellosis on bison and elk in the 
national parks and potential transmission of the disease to nearby 
domestic livestock, this study was designed to evaluate phenotypic and 
genotypic characteristics used for identification of the proposed vaccine 
strain RB51. The objectives of this study were to assess the stability 
of B. abortus strain RB51 determined by genomic fingerprint, oxidative 
metabolism, and colonial morphology, and to differentiate RB51 from 
isolates of Brucella recovered primarily from bison and elk. 
Materials and methods 
Brucellae. Brucella abortus strain RB51 was obtained from G. G. 
Schurig (Virginia Polytechnic Institute and State University, Blacksburg, 
VA). The seed was expanded to produce a new master seed stock referred 
to as "ARS/1". This stock has been used since 1990 for experiments 
conducted in the Brucellosis Cattle Test Program at the National Animal 
Disease Center, Ames, lA. 
The USDA's National Veterinary Services Laboratories (Ames, lA) 
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routinely obtains cultures and tissue samples from wildlife in the United 
States for the identification of Brucella species. Included in this 
study were samples from the states of WY, MT, SD, and ND. A total of 73 
isolates of B. abortus, which includes 38 from bison and 35 from elk were 
obtained and characterized. Stock cultures of each isolate were passed 
no more than three times before freezing (-80 C) or lyophilizing in WHO 
preservation medium (4). Brucella abortus strain 19 was obtained from R. 
D. Angus (NVSL) . The following were from the NADC culture collection: 
B. abortus strains 2308, 2308R, 19R, and 45/20, B. melitensis strain 16M, 
B. canis strain RM-666, and B. ovis strain 63/290. 
Isolates of RB51 were recovered from animal tissues sampled during 
vaccination projects done in cattle (7) and bison (25), Animals were 
part of experiments to determine the effects of vaccination with RB51 
against infection and abortion attributable to B. abortus. Strain RB51 
was isolated from biopsies of superficial cervical Ijrmph nodes of animals 
vaccinated with RB51 (7). In vitro passage of RB51 was 75, 96, or 159 
transfers on artificial medium established over 1.5 to 2.5 years. 
Growth of bacteria. Working cultures of Brucella were grown for 44 
h at 37°C on potato infusion agar or on tr3rptose agar (Difco Laboratories, 
Detroit, Ml) containing 5% bovine serum (TSA) before storing at 5°C. 
Growth of Brucella from tissue samples was on TSA; TSA with antibiotics 
(cycloheximide [30 ug/ml] , bacitracin [7.5 U/ml], and poljnnjrxin B sulfate 
[1.8 U/ml]) (4); TSA with antibiotics and ethyl violet (1:800,000) (4); 
Ewalt's medium (11); and Farrell's medium (12). 
Typing of Brucella. Brucellae were identified by routine typing 
techniques used for Brucella biotyping. Conventional methods used for 
characterizing the growth of Brucella isolates were performed as 
recommended by the Food and Agriculture Organization of the United 
Nations and the World Health Organization (4). Characteristics of 
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routine typing included tests for urease, H2S production, catalase, COj 
dependency, sensitivity to lysis by Tbilisi (Tb) bacteriophage, 
agglutination reactivity with A-, M-, and R-monospecific antisera, and 
growth in the presence of basic fuchsin, thionin, thionin blue, 
penicillin, and erythritol. 
Antibiotic sensitivity testing was done using modifications of the 
agar diffusion method (5). Discs containing antibiotics (Difco) were 
placed on TSA and zones of inhibition were determined after 48 h growth 
at 37°C. The following antibiotics were used: penicillin (10 U), 
rifampin (5 jug), amikacin (30 /ig), ampicillin (10 a*S) . carbenicillin (100 
/ig), doxycycline (30 ng), gentamicin (10 /xg), tetracycline (30 ng), 
kanamycin (30 /xg), streptomycin (10 /ig), novobiocin (30 /ig) , 
trimethoprim-sulfamethoxazole (1.25/ig/23.75 jug), and tobramycin (10 fig). 
DNA fingerprinting. DNA fingerprinting was done as previously 
described (16). Brucella DNA was extracted using modifications of the 
methods of Allardet-Servent, et al. (2). Cells were grown 18 h at 37°C on 
Brucella, agar (GIBCO Laboratories, Grand Island, NY), washed off with TE 
buffer (10 mM Tris hydrochloride [pH 8], 1 mM EDTA), suspended to a 
concentration of approximately 5 X 10® CFU/ml, and frozen (-20°C) until 
needed. Cells were thawed, mixed with an equal volume of 1% low melt 
agarose (Bio-Rad Laboratories, Richmond, CA), and dispensed into a mold 
chamber. Inserts were then incubated at 37°C for 48 h in 0.5 M EDTA with 
1% (w/v) SDS and 1 mg pronase (Calbiochem, La Jolla, CA)/ml. Protein 
digestion products were removed by washing inserts using TE plus 1 mM 
phenylmethylsulfonyl fluoride which inactivates pronase. Prior to 
digestion with restriction endonuclease, the agarose inserts were washed 
in TE for 1 h and equilibrated in 200 fxl of the digestion buffer for 0.5 
h at 37°C. Brucella DNA in the agar inserts were digested with 10 U of 
restriction endonuclease for 48 h at 37°C in 200 iil volumes containing the 
restriction endonuclease in the appropriate buffer, according to the 
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instructions of the manufacturer (GIBCO). The restriction endonucleases, 
Xba I, Afl II, Xho I, Spe I, Ssp I, and Dra I, were used. DNA 
preparations in agarose were stored in 0.05 M EDTA (pH 8.0) at 4°C. 
Electrophoresis of digested DNA was done using PFGE (33) in 1.5% 
agarose (Stratagene, La Jolla, CA) with TBE buffer (0.089 M Tris, 0.089 M 
boric acid, 0.002 M NajEDTA) (31) and the clamped homogeneous electric 
fields (CHEF) system (CHEF-DRII: Bio-Rad). The pulse times were 0.3-1.2, 
0.3-10, or 1-20 s for 40 h at 200 V. Lambda concatemers (New England 
Biolabs, Beverly, MA), chromosomes of Saccharomyces cerevisiae (Bio-Rad), 
and lambda digested with Hind III (Bio-Rad) were used as size markers. 
DNA was visualized with UV illumination after staining with ethidium 
bromide (0.5 mg/ml) and photographed. Size of fragments were determined 
with a computer-assisted analysis program by Biolmage Products, Ann 
Arbor, MI (Millipore Corporation). 
Oxidative metabolic profiles. Conventional manometric techniques 
were used to determine oxygen uptake for Brucella (20). The growth from 
tryptose agar roux flasks that had been incubated 48 h at 37°C in 10% CO2 
in air were suspended in Sorenson's buffer, washed, and 
spectrophotometrically standardized to 45% T +/- 2% (ODgoo). Substrates 
were dissolved in Sorenson's 0.06 M phosphate buffer and adjusted to pH 
7.0 when necessary. The standardized cell suspensions were then added to 
individual flasks. Each flask contained 1.0 ml cell suspension, 0.5 ml 
buffer containing 5 mg of the desired substrate, 1.4 ml buffer, and 0.1 
ml 20% KOH in the center well. Data were presented as microliters of 
oxygen used per hour per milligram of cell nitrogen (Q02(N)), with 
endogenous respirator rates subtracted. 
Colonial morphology. Monitoring for degree of "smoothness" was 
accomplished by using obliquely reflected light (15), acriflavine (6), 
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crystal violet (41), specific antisemm (3, 4), and Tb bacteriophage 
(17). 
Individual clones of RB51 were examined to ascertain if 
inducibility into smooth colonial forms would occur. This was done by 
growing RB51 on TSA for 72 h at 37°C. Resulting growth was harvested in 
10.0 ml of 0.85% NaCl and adjusted to contain 2 X 10^  CFU/ml. One-half ml 
of this suspension was plated onto 10 plates of TSA containing 0, 0.9, 
1.8, or 3.6 U of polymjrxin B per ml. After 72 h of incubation, colonies 
were examined using obliquely reflected light, plates were flooded with 
crystal violet (41) for 15 to 20 s, and approximately 30 "unstained" 
colonies were selected and inoculated onto separate slants and each 
examined as a separate strain. This procedure was repeated. 
Micro-dot blot. Detection of 0-antigen of smooth Brucella LPS was 
done by immunoblotting. Bacteria were fixed overnight in 67% methanol, 
dotted (0.5 fxl) onto nitro-cellulose membranes (0.45 urn pore size; 
Schleicher & Schuell, Inc., Kene, NH), and allowed to dry. Membranes 
were immersed in 10 mM phosphate-buffered saline (PBS; pH 7.2) containing 
0.05% Tween 20 (TPBS) and 0.9% gelatin (Difco) and incubated 30 m at room 
temperature. Monoclonal antibody to LPS (26) was applied and incubated 
for 1 h at 37°C. Immunocomplexes were detected with biotinylated rabbit 
anti-mouse IgG (Vector Laboratories, Burlingame, CA) followed by 
Vectastain ABC reagent (Vector) with 4-chloro-l-naphthol (Bio-Rad) as the 
substrate. Brucella abortus strain 2308 and S. melitensis strain 16M 
were used as positive controls; B. canls strain RM-666 and B. ovis strain 
63/290 were used as negative controls. 
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Results 
Bacteriological analysis. Bnxcella isolates from bison and elk 
were biotyped as B. abortus biovar 1 (not strain 19). Strain RB51 and 
laboratory and animal passages of RB51 differed from the tjrpical B. 
abortus biovar 1 (Table 1) in that they did not contain the A- or M-
antigen, were not lysed by Tb bacteriophage, and lacked the 0-antigen as 
determined by immunoblot. Field isolates of B. abortus biovar 1 usually 
required COj for growth; whereas, strains RB51, 19, and 2308 did not. 
Production of HjS was weak for 2308 when compared to field isolates. 
Strain 19 did not grow in the presence of thionin blue, penicillin, and 
erythritol. 
Resistance to rifampin for RB51 remained after in vivo and in vitro 
passages. These isolates did not show cross-resistance to structurally 
unrelated therapeutic agents. Strain RB51 was sensitive to tetracycline, 
amikacin, carbenicillin, doxycycline, gentamicin, kanamycin, 
streptomycin, novobiocin, penicillin, and tobramycin; but was resistant 
to trimethoprim-sulfamethoxazole and had intermediate susceptibility to 
ampicillin. Isolates of RB51 before and after in vivo and in vitro 
passages grew on tryptose agar containing 5 U of penicillin per ml, 
whereas strain 19 did not. 
Restriction enzyme analysis. The restriction endonucleases that 
were used varied in their ability to discriminate between isolates. The 
DNA fingerprint of strains RB51, 19, and 2308 were specifically compared 
using the restriction endonucleases: Xba I, Afl II, Xho I, Spe I, Ssp I, 
and Dra I. Among those enzymes, only Xba I had the ability to 
differentiate RB51 from 19 and 2308 (Fig, 1). No discriminative profiles 
were detected when Afl II, Xho I, Spe I, Ssp I, and Dra I were used (data 
not shown), therefore, Xba I was used throughout the study. The 
reproducibility of the technique was established by repeat testing, which 
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yielded identical fingerprint patterns. 
Gels that ran at different pulse times gave similar comparative 
results and provided better separation for a given size range. Shorter 
pulses resolved smaller fragments of DNA (Fig. 2); longer pulses resolved 
the larger fragments. The consistency of the profile for RB51 was 
determined by testing the same isolate on four separate occasions. 
Analysis using large restriction fragments produced from digesting 
genomic DNA with Xba. I and separating these fragments by PFGE allowed 
visual separation of RB51 from field isolates of Brucella. 
Macrorestriction fingerprinting using Xba I produced 3 fragments in the 
size range of 150-250 kb, and multiple fragments smaller than 125 kb were 
generated. Fragment patterns were conserved among the field isolates of 
B. abortus from bison and elk (Fig. 3). Differentiation of RB51 and 2308 
from field isolates and strain 19 was based on variable bands at 109, 
104, 21, and 17 kb (Fig. 1, Table 2). Strain RB51 differed from 2308 in 
that it had a 17kb fragment instead of a 21 kb fragment (Fig. 2). 
Profiles of strains 19 and RB51 did not change after isolation from 
vaccinated cattle or bison. Some of the isolates from elk were strain 
2308 which were recovered from elk that were experimentally infected with 
2308 (Fig. 3C, lanes 1 and 2). 
Long-term laboratory passage of RB51, 19R, and 2308R produced no 
detectable changes in restriction endonuclease patterns (data not shown). 
Animal passage of RB51 did not show change in the profile (Fig. 1). 
Oxidative metabolism. Graphic representation of the oxidative 
metabolic profiles of RB51, RB51/HP, RB51/cow, and RB51/bison had similar 
profiles (Fig. 4). They had the tjrpical oxidative metabolic pattern of 
B. abortus on 13 of 13 substrates which are currently used for 
differentiating species and biovars of Brucella. The Q(02N) rates of RB51 
were compared with 19 and field isolates of B. abortus biovars 1, 2, and 
4 (Table 3). 
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Strain RB51, whether of repository origin (ARS/1) or isolated from 
animals utilized L-glutamic acid, L-alanine, D-alanine, and L-asparagine. 
The substrates of the urea cycle (L-arginine, DL-ornithine, and D,L-
citrulline) were not substantially oxidized by any of the RB51 isolates. 
The carbohydrates tested (L-arabinose, D-galactose, D-ribose, D-glucose, 
and i-erythritol) were all utilized by the RB51, RB51/cow, RB51/bison, 
2308, and typical B. abortus biovars 1, 2, and 4. Strain 19 was distinct 
from the rest of the isolates of B. abortus biovars 1, 2, and 4 in that 
it typically fails to utilize i-erythritol. The oxidative metabolic rate 
for the high passage in vitro RB51 utilizing L-arabinose or D-glucose was 
approximately twice the rate for RB51 and RB51 passed in cow or bison 
(Fig. 4). 
Colonial morphology. Direct examination of colonies of RB51 
(before and after in vivo and in vitro passages) by obliquely reflected 
light were dry, granular, yellow to yellow-white in color. In contrast, 
19 and 2308 had smooth colonies that were round, glistening, blue to 
blue-green in color. Colonies of 19 and 2308 did not stain with crystal 
violet, and failed to agglutinate in the presence of acriflavine. The 
isolates of RB51 agglutinated with acriflavine and colonies were stained 
by crystal violet. These isolates did not react with A or M antisera, 
but did react with R antisera. The smooth bacteriophage (Tbilisi) failed 
to lyse them. The isolates did not react by immunoblotting with 
monoclonal antibody to LPS, whereas 2308 and 19 did. 
Growth of RB51 was completely inhibited on TSA containing 3.6 U/ml 
by polymyxin B (data not shown). Number of CFUs of RB51 on TSA with 
antibiotics (i.e., [polymjrxin B] = 1.8 U/ml) was reduced by approximately 
85%. In contrast, strain 19 and the parental strain 2308 were not 
inhibited on TSA containing 3.6 U/ml. Strain RB51 passed 159 times on 
TSA with antibiotics ([polymjrxin B] = 1.8 U/ml) was not inhibited on TSA 
containing 1.8 U/ml, but failed to grow on TSA containing 3.6 U/ml. 
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Direct observation of RB51 and high passage of RB51 using obliquely 
reflected light did not reveal smooth colonial forms. Colonies stained 
with crystal violet, agglutinated in the presence of acriflavine, and did 
not lyse by Tb bacteriophage. The presence of 0-antigen of Brucella 
smooth LPS was not detected by micro-dot blot. The R-antigen was 
present, but not A or M. Strains 19 and 2308 retained smooth 
characteristics. Repeated attempts to isolate smooth colonial forms of 
RB51 from cattle and bison were not successful. 
Discussion 
The profile of RB51 is unique from Brucella isolated from cattle, 
bison, and elk based on comparison of total DNA fingerprints. 
Macrorestriction genomic fingerprinting using PFGE considers the overall 
organization of the bacterial genome and may be an indicator of clonal 
origin and genetic relatedness. Absence of noticeable differences in the 
banding patterns of B. abortus isolated from bison and elk indicates that 
these isolates are clonally related. The patterns were similar to those 
reported for B. abortus biovars 1, 2, and 4 isolated from cattle (16). 
Three other profiles were reported for B. abortus and they were detected 
in 1) B. abortus strain 11 (biovar 1), 2) B. abortus biovar 3, and 3) B. 
abortus biovars 5, 6, and 9 (16). 
Correlation of PFGE patterns with biotyping of Brucella indicates 
that a low genetic diversity exists within B. abortus biovar 1 isolated 
from bison and elk. The striking feature is the monomorphism in B. 
abortus from bison and elk and in B. abortus biovars 1, 2, and 4 isolated 
from cattle (16), regardless of geographical origin (within USA) or host 
(cattle, bison, or elk). The presence of genomic fragments that are 
similar in size does not attest that the fragments are the same, but 
would suggest that strains of B. abortus which are limited in nature to 
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the bovine host are closely related to the strains of which can replicate 
repeatedly in bison or elk. 
The oxidative metabolic profiles for RB51 before and after in vivo 
or in vitro passage were characteristic of the profile reported for B. 
abortus (40). There are three levels of utilization for Brucella species 
(40). The first level uses four substrates, L-glutamic acid, L-alanine, 
D-alanine, and L-asparagine, which are always utilized by B. abortus and 
B. melitensis. Second level, uses the next four substrates, L-arginine, 
DL-omithine, D,L-citrulline, and L-lysine, three of which are amino 
acids from the urea cycle and are usually utilized by B. suis but not by 
B.abortus or B. melitensis. Utilization of the carbohydrate substrates 
vary from species to species. Profiles produced from B. ovis, B. canis, 
and B. neotomae differ from each other, and from the other three species 
(B. abortus, B. melitensis, B. suis). 
There were no definite differences in the magnitude or 
relationships of the rates between the isolates of RB51 and tjrpical field 
isolates of B. abortus biovars 1, 2, or 4. However, the oxidative 
metabolic rate for the high passage in vitro RB51 utilizing L-arabinose 
or D-glucose was approximately twice the rate for RB51. Brucellae 
maintained under laboratory conditions retain characteristic species 
metabolic pattern, but may have higher oxidative rates on some substrates 
than recent Isolates (19). 
Strain RB51 maintains rough characteristics after in vivo and in 
vitro passages as shown in this study and by others (29, 32). The A-, 
M-, or 0-antigen of smooth strains of Brucella was not demonstrated after 
passage, but RB51 did retain reactivity with R antiserum. Resistance to 
rifampin was consistent and no cross-resistance to structurally unrelated 
therapeutic agents was demonstrated as was reported for spontaneous 
rifampin-resistant variants recovered from rifampin-containing medivun 
(10). Colonial morphology of RB51 remained rough. 
In this study, poljnnyxin B was used as a selective agent in the 
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attempt to obtain smooth colonial forms of RB51 as this strain is more 
sensitive to polymyxin B than its parental strain 2308. Brucella LPS is 
unique in that it does not bind polymyxin B (23, 24), unlike LPS from 
many other Gram-negative bacteria (28). Polymyxin B binds 
electrostatically to outer membranes disrupting the structure of 
phospholipid and LPS components, due to its cationic detergent-like 
properties (13). Farrell (12) has reported that the MIC of polymyxin B 
sulfate was 10 to 160 U/ml for 95 smooth Brucella strains typed as B. 
abortus biovars 1, 2, 3, 4, 5, 6, or 9; B. melitensis biovars 1, 2, or 3; 
or B. suis biovar 1. In addition, the rough B. canis is resistant to 
polymyxin B (37); however, selective meditim recommended for isolation of 
rough B. ovis from field samples does not contain polymjrxin B (4). 
The LPS in the outer membrane of Brucella may be responsible for 
excluding interactions of polymyxin B with the phospholipids (e.g., 
phosphatidylcholine; 14) of the outer leaflet of the outer membrane. 
When phospholipids of this leaflet are exposed, as with RB51, the outer 
membrane is susceptible to polym3ncin. The inability of RB51 to grow on 
media containing the higher levels of polymyxin B indicated that smooth 
LPS was absent, thus allowing the antibiotic to interact with the cell 
membrane. 
Although strain-to-strain differences are small they permit 
discrimination of B. abortus strain RB51 from other brucellae. Since the 
reliability of bacterial markers for epidemiological investigations 
depends on diversity and reproducibility, this method of genomic 
"fingerprinting" by means of PFGE provides an effective and highly 
specific epidemiological tool for pursuing the source, transmission, and 
spread of the vaccine strain RB51. The results of the present study 
indicate that the genomic fingerprint, oxidative metabolism, and rough 
colonial morphology of RB51 are stable characteristics and can be used to 
differentiate this potential vaccine candidate from other isolates of 
Brucella from infected cattle, bison, and elk. 
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Table 1. Characteristics of Brucella abortus strains RB51, 19, and typical biovar 1. 
STRAIN CO, H^ S UREASE CATALASE BASIC THIONIN 
FUCHSIN 
THIONIN PEN. ERYTH. ANTIGEN LYSIS 
BLUE A. M. R PHAGE 
Typical 
biovar 1 +/- + + 
RB51 - + + 
RB51/HP - + + 
RB51/COW - + + 
RB51/blson - + + 
19 . + + 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ + + 
+ + + 
+ + + 
+ + + 
+ + + 
A 
R 
R 
R 
R 
A 
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Table 2. Characteristics distinguishing B. abortus strain RB51 from B. 
abortus strains 2308 and 19, and typical biovar 1 strains. 
CHARACTERISTIC RB51 
ISOLATES 
2308 
TYPICAL 
BIOVAR 1 19 
Xba. I fragment: 
109 kb 
104 kb 
21 kb 
17 kb 
Colonial 
morphology 
Rifampin 
sensitivity 
Lysis by phage 
Agglut ination 
in sera: 
A 
H 
R 
Immunoblot w/ 
MoAb to LPS 
CO2 requirement 
rough 
+ 
+ 
smooth 
+ 
+ 
smooth 
resistant sensitive sensitive 
+ + 
+ 
+/-
+ 
+ 
smooth 
sensitive 
+ 
Table 3. Oxidative metabolic values, QOoCN)*, of Brucella abortus for 
selected amino acids and carbohydrates. 
Isolates Substrates 
D- L- L- L- DL- DL-
alanine alanine asparagine glutamate ornithine citrulline 
RB51 271 245 411 428 83 68 
RB51/HP 287 217 428 432 70 116 
RB51/Bovine 303 260 441 408 68 92 
RB51/Bison 244 199 367 350 95 92 
Biovar l'' 152 150 215 250 50 39 
Biovar 2® 156 119 237 201 15 8 
Biovar 4*^  166 160 234 191 30 35 
19« 96 176 216 616 93 47 
® Q02(N) - microliters of oxygen uptake per milligram of nitrogen per hour 
** Mean Q02(N) values for B. abortus biovar 1 
° Mean QOjCN) values for B. abortus strain 2 
 ^Mean QOjCN) values for B. abortus strain 4 
® Mean QOjCN) values for strain 19 
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Substrates 
L- L- L- D- D- D- i-
arginine lysine arabinose galactose ribose glucose ervthrltol 
104 114 261 435 596 346 454 
122 56 612 485 629 667 568 
112 74 301 444 636 377 571 
78 64 262 378 447 375 404 
50 42 156 270 376 206 315 
11 8 139 192 379 257 498 
46 28 150 251 481 268 410 
85 30 126 246 294 388 25 
FIG. 1. Pulsed-field gel electrophoresis (PFGE) of Xba I 
digests of DNA from Brucella abortus strains. 
Lanes: 1, 45/20; 2, 2308; 3, RB51; 4, RB51 from 
cow (post-vaccination 8 weeks); 5, RB51 from cow 
(post-vaccination 10 weeks); 6, 19 from cow 
(post-vaccination 8 weeks). Size of discerning 
fragments are indicated on the right. Positions 
of size (kb) markers are indicated on the left. 
1 2 3 4 5 6 
291.0^ 
242.5^ 
194.0' 
145.5 
97.0 -
-109 
-104 
FIG. 2. Pulsed-field gel electrophoresis (PFGE) of Xba I 
digests of DNA from Brucella abortus strains RB51 
(lane 1) and 2308 (lane 2). Arrows indicate 
differentiating bands. Positions of size (kb) 
markers are indicated on the left. 
48.5 
23.1 -
12.2 -
FIG. 3. The PFGE of Xba I digests of DNA from B. abortus 
strain RB51 (B) and B. abortus biovar 1 isolated 
from bison (A) and elk (C). A) Lane 1, RB51; 2 
and 4-8, isolates from bison of the Greater 
Yellowstone Area; and 3, uncut DNA from an 
isolate from bison. C) Lanes 1-2, isolates from 
2308-infected elk; 3 and 5-10, representative 
isolates from elk; and 4, uncut DNA from an 
isolate from elk. Positions of size (kb) markers 
are indicated. 
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FIG. 4, Oxidative metabolic profiles of B. abortus strain 
RB51 before and after in vivo (cow or bison) or 
in vitro (HP = high passage) passages. Rates of 
oxygen uptake on selected amino acid and 
carbohydrate substrates are reported as Q02(N) 
values (fil of oxygen uptake per mg of nitrogen 
per hour) . 
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GENOME FINGERPRINTING AND THE DEVELOPMENT OF A DENDROGRAM 
FOR BRUCELLA SPECIES INCLUDING ISOLATES FROM SEAL, PORPOISE, 
AND DOLPHINS 
Manuscript^  to be submitted for publication in 
Journal of Clinical Microbiology 
A. E. Jensen,N. F. Cheville,^ M. A. Wilson/ 
and C. 0. Thoen,® 
Abstract 
Genomic DNA from reference strains and biovars of Brucella was 
analyzed using pulsed-field gel electrophoresis (PFGE). Fingerprints 
were compared to estimate genetic relatedness among the strains and 
obtain information on evolutionary relationships. Electrophoresis of DNA 
digested with the restriction endonuclease, Xba I, produced fragment 
profiles for the reference type strains that distinguished these strains 
 ^No endorsements are herein implied. Brand names are necessary to report 
factually on available data; however, the USDA neither guarantees nor 
warrants the standards of the products, and the use of the names by USDA 
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to the level of species. Included in this study were four strains of 
Brucella isolated from marine mammals. The PFGE profiles from these 
strains were compared with those obtained from reference strains and 
biovars of Brucella. The two isolates from dolphins had similar profiles 
and distinct profiles from Brucella strains isolated from seal and 
porpoise. Distance matrix analyses were done and a dendrogram was 
constructed. Biovars of B. abortus were clustered together in the 
dendrogram; similar clusters were shown for biovars of B. melitensis and 
for biovars of B. suis. Brucella ovis, B. canis, and B. neotomae 
differed from each other, and from B. abortus, B. melitensis, and B. 
suis. The relationship of B. abortus strain RB51 with Brucella was 
compared as this strain has been proposed to replace B. abortus strain 19 
for use as a vaccine. These results support the current taxonomy of 
Brucella species and also support the designation of an additional 
genomic group(s) of Brucella. The PFGE analysis in conjunction with 
distance matrix analysis served as a useful tool for calculating genetic 
relatedness among the Brucella species. 
Introduction 
The genus Brucella is currently classified into six species (i.e., 
B. abortus, B. melitensis, B. suis, B. ovis, B. canis, and B. neotomae) 
that closely correlate with their preferred natural hosts and pathogenic 
properties (6, 21). Brucellae are described by colony and cellular 
morphology. Gram's reaction, agglutination with mono-specific antisera, 
and results in routine biochemical tests (4, 16). The species are 
separated on the basis of lysis by bacteriophage and oxidative profiles 
on selective amino acid and carbohydrate substrates (4). Typing isolates 
of Brucella into biovars uses conventional procedures for determination 
of morphology, cultural characteristics, CO2 requirement, H^ S and urease 
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production, sensitivity to erythritol and dyes (thionin, basic fuchsin, 
and thionin blue), agglutination with mono-specific antisera (A, M, or R 
antigens), susceptibility to antibiotics, and lysis by Brucella 
bacteriophages (3). Atypical strains exist and these are usually 
identified as fitting a certain Brucella species biovar except for the 
stated differences. 
Recently, Brucella was isolated from internal organs of four common 
seals (Phoca phocoena), two harbor porpoises (Phocoena phocoena), and one 
common dolphin (.Delphinus delphis) (18). These marine manmials were among 
strandings found around the Scottish coast. In the same year, 
characteristics of another isolate of Brucella from an aborted fetus of a 
bottlenose dolphin (^ Tursiops truncatus) at the Balboa Hospital, San 
Diego, CA were described (8). The authors used several approaches 
including analysis of biochemical and oxidative metabolism profiles, 
protein profiles, and virulence in guinea pigs. The bacterial isolates 
from marine mammals were reported as belonging in the genus Brucella, but 
not matching any known species. 
The species of Brucella are very homogeneous in terms of high DNA-
DNA hybridization (7, 12, 13, 22). Restriction endonuclease analysis 
(REA) of genomic DNA digested with high frequency cleavage enzymes are of 
limited use in differentiating strains of Brucella (17). Alternately, 
pulsed-field gel electrophoresis of genomic DNA digested with restriction 
endonucleases which cut infrequently has been used to separate Brucella 
species (1, 14). In our laboratory, DNA fingerprinting has been used to 
differentiate the proposed vaccine B. abortus strain RB51 from other 
brucellae (14, 15). Digestion of total DNA with the restriction 
endonuclease Xba I followed by pulsed-field gel electrophoresis proved to 
be beneficial. 
In the present study, we examined the potential utilization of PFGE 
as a device for the determination of genetic relationships of the 
Brucella species. Ue investigated the genetic relationships of 4 new 
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isolates of Brucella from marine manunals along with the reference strains 
and biovars of Brucella. Results were evaluated to determine clonal 
relationships of Brucella species. 
Materials and methods 
Brucellae. Strains of Brucella (Table 1) were grown for 42 to 72 h 
at 37°C on potato infusion agar or on tryptose agar (Difco Laboratories, 
Detroit, MI) containing 5% bovine serum before storing at 5°C. Stock 
cultures of each isolate were passed no more than three times before 
freezing (-80 C) or lyophilizing in WHO preservation medivim (4). The 
FAG/WHO (Food and Agriculture Organization of the United Nations and the 
World Health Organization) reference strains and biovars of Brucella 
(Table 1) were analyzed. Also included in this study were: B. abortus 
strain 19 (obtained from R. D. Angus; NVSL, Ames, lA), the GA dolphin 
isolate (D. R. Ewalt; NVSL), and B. abortus strains 2308 and RB51 (NADC). 
Brucella abortus strain RB51 was obtained from G. G. Schurig (VPI and 
State University, Blacksburg, VA); this culture was expanded to produce a 
new master seed stock referred to as "ARS/1". Isolates from dolphin, 
porpoise, and seal were provided by A. P. MacMillan (Central Veterinary 
Laboratory, Weybridge, UK). 
Genomic fingerprinting. The DNA fingerprinting was done as 
described (14). Brucella DNA was extracted using modifications of the 
methods of Allardet-Servent, et al. (1). Briefly, cells were grown 18 to 
36 h at 37°C on Brucella agar (GIBCO Laboratories, Grand Island, NY), 
washed off with TE buffer (10 mM Tris hydrochloride [pH 8], 1 mM EDTA), 
suspended to a concentration of approximately 5 X 10® CFU/ml, and frozen 
(-20°C) until needed. Cells were thawed, mixed with an equal volume of 1% 
low melt agarose (Bio-Rad Laboratories, Richmond, CA), and allowed to 
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solidify in a mold chamber. Inserts were removed from the molds and then 
incubated at 37°C for 48 h in 0.5 M EDTA with 1% (w/v) SDS and 1 mg 
pronase (Calbiochem, La Jolla, CA)/ml. Protein digestion products were 
removed by washing inserts twice using TE with 1 mM phenylmethylsulfonyl 
fluoride which inactivates pronase. Prior to digestion with restriction 
endonuclease, the agarose inserts were incubated three times in TE for 1 
h for each incubation period and then equilibrated in 200 /il of the 
digestion buffer for 0.5 h at 37°C. Brucella DNA in the inserts were 
digested with 10 U of restriction endonuclease for 48 h at 37°C in 200 fil 
volumes containing the restriction endonuclease in the appropriate 
buffer, according to the instructions of the manufacturer (GIBCO). The 
restriction endonucleases, Xba I was used. Inserts containing the DNA 
preparations were stored in 0.05 M EDTA (pH 8.0) at 4°G. 
Electrophoresis of digested DNA was done by PFGE (20) in 1.5% 
agarose (Stratagene, La Jolla, CA) with TBE buffer (0.089 M Tris, 0.089 M 
boric acid, 0.002 M Na2EDTA) (19) and the clamped homogeneous electric 
fields (CHEF) system (CHEF-DRII: Bio-Rad). The pulse times were 0.3-10 
or 3-20 s for 41 h at 200 V. Lambda concatemers (New England Biolabs, 
Beverly, MA) and lambda digested with Hind III (Bio-Rad) were used as 
size markers. DNA was visualized with UV illumination after staining 
with ethidium bromide (0.5 mg/ml) and photographed. 
Data analysis. The PFGE profiles were analyzed by an automated 
computer-assisted analysis program (Biolmage Products, Millipore 
Corporation, Ann Arbor, MI). Size of fragments in photographs of each 
genomic profile was determined by comparing to size markers. The program 
computed the similarities for each pair of Brucella strains on the basis 
of position and intensity of bands in the profiles. Dendrograms were 
generated using the per cent similarities to each other. 
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Results 
Fulsed-field eel electrophoresis. Digestion of Brucella genomes 
with Xba I resulted in fingerprints each consisting of 25 to 35 
restriction fragments that ranged in size from 10 to 350 kb (Figs. 1, 2). 
The PFGE analysis of Brucella DNA digested with Xba I revealed species 
differences in the genomic fingerprints. Unique electrophoretic 
differences were discernible among B abortus, B melitensis, B suis, B 
ovis, B canis, B neotomae, and strains isolated from each species of the 
marine mammals. Conventional gel electrophoresis showed that Xba I 
generated no detectable fragments smaller than those shown when using 
PFGE (data not shown). Attempts to resolve intact B. abortus genome by 
PFGE using pulse times greater than 45 s were unsuccessful (data not 
shown), 
Profiles of reference biovars of B abortus were similar, however 
some differences in genomic fingerprint profiles were seen (Fig. lA). 
Differences were observed in regions at 128 and greater than 193 kb. 
Profiles of biovars 1, 2, and 4 (Fig. lA, lanes 1, 2, and 4) were 
similar, as were those of biovars 5 and 9 (Fig. lA, lanes 5 and 7). The 
profile of biovar 3 (Fig. lA, lane 3) was similar to that of biovars 5 
and 9; this profile lacked a band at 93 kb and contained additional bands 
at 65 and 67 kb. The fingerprint of B abortus strain RB51 (data not 
shovm) contained an additional 17 kb fragment and had a 104 kb fragment 
instead of the 109 kb fragment present in the reference biovars of B. 
abortus. 
Differences in profiles were demonstrated for the biovars of B.suis 
(Fig. IB) and B. melitensis (Fig. 2A). Brucella ovis, B. canis, and B. 
neotomae (Fig. 2B) were each different from each other and from the other 
Brucella species (Fig. 1, 2). The two isolates from dolphins had similar 
profile to each other and distinct from profiles from the isolates from 
seal and porpoise (Fig. 2C). The profiles obtained from the isolates 
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from marine mammals were different from those of the other Brucella 
species. 
Genetic relatedness determined bv PFGE. Profiles were analyzed 
using the computer assisted program to determine genetic relatedness 
among the strains. A lane map (Fig. 3) generated from photographs of 
ethidium stained DNA showed the profiles used in the formation of the 
dendrogram. The dendrogram revealed that from the 22 isolates a total of 
7 major PFGE types were established at 43% relatedness (Fig. 4). Each 
major PFGE type contained strains which were classified as clonal 
variants. The distribution of the Brucella strains was in agreement with 
the separation of species with their ascribed biovars. 
Discussion 
Fingerprint strategy allowed determination of genetic relatedness 
of Brucella isolates based upon restriction enzyme profile. The enzyme 
Xba I was selected for typing studies because it produced restriction 
patterns that discriminated between isolates. The recognition sequence 
(5'-TCTAGA-3') for Xba I has been reported to occur rarely in genomes of 
many gram-negative bacteria (23). It has been used in the construction 
of a physical map for B. melitensis strain 16M (2) and in the 
differentiation of the vaccine B. abortus strain RB51 from other 
brucellae (14, 15). 
Interpretation of genomic fingerprinting is complicated by use of 
other REs that could be used by other researchers for evaluating Brucella 
isolates. Digestion of genomic DNA with Xba I provided results that 
distinguished Brucella species as reported herein. Different REs may 
supply additional evidence for establishing genetic relatedness among the 
strains; however, profiles generated from digestion with Xba I were 
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easily interpreted and would provide preliminary evaluation on genomic 
fingerprinting of Brucella which could be standardized between 
laboratories. 
Exact identification of Brucella species isolated from mammals is 
of importance especially when these identifications are epidemiologically 
or diagnostically relevant. It must be recognized, that Brucella 
populations have their own typical ecological niches and that these 
populations can be characterized and recognized by serotyping and 
biotyping. The epidemiological significance of this ecovar distinction 
is evident. However, other mammalian species may occasionally become 
infected, but the Brucella ecovar does not perpetuate or spread in that 
animal species. 
The distinction of Brucella species were made in the past, because 
biotyping (serogrouping) and certain biochemical reactions were widely 
used in routine diagnostic bacteriology. Recently, it was proposed that 
Brucella isolated from a dolphin (CA/dolphin; NVSL2-1350) represented a 
new Brucella species (8). The species identity of this isolate was not 
determined since it did not agree with current species descriptions. The 
fingerprints of the isolates from marine mammals were different from any 
recognized Brucella species. The clustering pattern in the dendrogram 
indicates that dolphin isolates resides peripherally to the other 
Brucella isolated from marine mammals. 
Supplementation of PFGE analysis with routine systemic description 
of the microorganism may be beneficial. The technique may be applied 
when necessary in combination with biotyping to discern distinct groups 
that are typically associated with certain hosts or even with certain 
sites. Results of the present study support the host species-specific 
concept. Currently, six genomic groups of Brucella are recognized based 
on two main set of properties; lysis by bacteriophages and oxidative 
metabolic profiles on selected amino acid and carbohydrate substrates 
(4). The bacterial isolates from marine mammals represent atypical 
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strain(s) or species of Brucella that have adapted to the marine 
environment. Host-adapted ecovars possibly occur because of (recent) 
evolutionary changes that developed in isolated bacterial populations. 
Cluster analysis provides a method of assigning strains to groups 
on the basis of similarities. Fingerprint relatedness among the isolates 
was low indicating genetic rearrangements of the genomes that are 
reported to be closely related by DNA-DNA hybridization studies (7, 12, 
13, 22). Variation in fragment size or organization of the profiles 
between biovars may result from recombination between repetitive 
sequences in the genome (5, 10, 11). Polymorphisms may be the result of 
a point mutation in a restriction site or a DNA rearrangements such as an 
insertion, deletion, or inversion (9). 
Genomic macrorestriction endonuclease fingerprinting using PFGE 
considers the overall organization of the bacterial genome and may be an 
indicator of clonal origin and genetic relatedness. It is conceivable 
that although most genomes of Brucella species identified as members of 
the same clone are identical or nearly so, several may have different 
ancestries and be derived by horizontal (transmissible) transfer from 
other clones of the same or different species. In svimmary, PFGE analysis 
of Xba I digested genomes has been shown to be useful as a tool for 
discrimination among Brucella species and supports the designation of an 
additional genomic group(s) of Brucella. 
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TABUS 1. FAO/WHO reference strains and biovars of Brucella 
Snecies Biovar Strain Host OriEin ATTC# 
B. abortus 1 
1 
3 
4 
5 
6 
9 
544 
86/8/59 
Tulya 
292 
B3196 
870 
068 
Cattle 
Cattle 
Human 
Cattle 
Cattle 
Cattle 
Cattle 
England 
England 
Uganda 
England 
England 
Africa 
England 
23448 
23449 
23450 
23451 
23452 
23453 
23455 
B. melxtensis 1 
2 
3 
16M 
63/9 
Ether 
Goat 
Goat 
Goat 
US 
Turkey 
Italy 
23456 
23457 
23458 
B. suis 1 
2 
3 
4 
5 
1330 
Thornsen 
686 
40 
513 
Pig 
Pig 
Pig 
Reindeer 
Rodent 
US 
Denmark 
US 
USSR 
USSR 
23444 
23445 
23446 
23447 
a 
B. ovis 63/290 Sheep Africa 25840 
B. canis RM-666 Dog US 23365 
B. neotomae 5K33 Wood rat US 23459 
Brucella spp. CA/dolphin Dolphin US b 
Dolphin 1 Dolphin Scotland c 
Seal 2 Seal Scotland c 
Porpoise 1 Porpoise Scotland c 
* Reference strain 513 has not been deposited in the ATCC. 
Provided by D. Ewalt, National Veterinary Service Laboratories, Ames, 
lA. 
° Provided by A. P. MacMillan, Central Veterinary Laboratory, Weybridge, 
UK. 
FIG. 1. Pulsed-field gel electrophoresis of Xba I digests 
of DNA from reference biovars of Brucella abortus 
(A) and B. suis (B). A) Lanes: 1, biovar 1; 2, 
biovar 2; 3, biovar 3; 4, biovar 4; 5, biovar 5; 
6, biovar 6; 7, biovar 9. B) Lanes: 1, biovar 
1; 2, biovar 2; 3, biovar 3; 4, biovar 4; 5, 
biovar 5. Positions of size (kb) markers are 
indicated on the left. 
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FIG. 2. The PFGE of Xba I digests of DNA from reference 
biovars of B. melitensis (A), B. ovis (B), B. 
canis (B), B. neotomae (B), and Brucella isolates 
from marine mammals (C). A) Lane 1, biovar 1; 2, 
biovar 2; and 3, biovar 3. B) Lane 1, B. ovis; 
2, B.canis; and 3, B. neotomae. C) Lane 1, Seal 
1; 2, Porpoise 1; 3, Dolphin 1; and 4, 
GA/dolphin. Positions of size (kb) markers are 
indicated. 
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FIG. 3. Computer generated lane map of Xba I restriction PFGE profiles of 
reference strains and biovars of Brucella abortus (Ba), B. 
melitensls (Bm), B. ovis (Bo), B. canis (Be), B. neotomae (Bn), B. 
suis (Bs), and Brucella isolates from marine mammals. Lane 1, Ba 
RB51: 2, Bal; 3, Ba2; 4, Ba3; 5, Ba4; 6, Ba5; 7, Ba6; 8, Ba9; 9, 
Bml; 10, Bm2: 11, Bm3; 12, Bo; 13, Be; 14, Bn; 15, Bsl; 16, Bs2; 
17, Bs3; 18, Bs4; 19, Bs5; 20, Seal 2; 21, Porpoise 1; 22, Dolphin; 
and 23, CA/Dolphin. Positions of size (kb) markers are indicated. 
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Brucella isolated from marine mammals. Percent 
related is indicated on the scale. 
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ULTRASTRUCTURE OF CELL ENVELOPE COMPONENTS OF SMOOTH (2308) 
AND ROUGH (RB51) STRAINS OF BEUCELLA ABORTUS 
Manuscript^  to be submitted for publication in 
Journal of Clinical Microbiology 
A. E. Jensen,N. F. Cheville,^ 
and C. 0. Thoen^  
Abstract 
Brucella abortus strains 2308 (smooth) and RB51 (rough) were 
characterized using transmission electron microscopy. Cell wall 
structure was examined using negative staining with phosphotungstic acid 
and thin-section techniques which included glutaraldehyde-osmium, 
ruthenium red, alcian blue, and osmium staining procedures. Negative 
staining showed that RB51 and 2308 had convoluted or wrinkled surfaces 
with occasional vesicular structures protruding from the surface. Strain 
RB51 cells were rod-shaped rather than coccobacillary as typical for 2308 
and was less convoluted than 2308. Negative staining did not demonstrate 
 ^No endorsements are herein implied. Brand names are necessary to report 
factually on available data; however, the USDA neither guarantees nor 
warrants the standards of the products, and the use of the names by USDA 
implies no approval of the products to the exclusion of others that may also 
be suitable. 
 ^Brucellosis Research Unit, National Animal Disease Center, Agricultural 
Research Service, USDA, Ames, lA 50010. 
 ^Corresponding author. 
 ^Department of Microbiology, Immunology, and Preventative Medicine, College 
of Veterinary Medicine, Iowa State University, Ames, lA 50011. 
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differences between 2308 and RB51 in surface structures or appendages 
(i,e., capsule, pili, flagella, microfilaments). Thin sectioning 
revealed three distinct layers typical of Gram-negative cell wall 
morphology: an outer membrane (6-8 nm), a cytoplasmic membrane (7 nm), 
and a homogeneous electron-dense periplasm of variable thickness (5-30 
nm) separating the outer and cytoplasmic membranes. The periplasm was of 
variable electron density but typically composed of granular material. 
The cell surface varied between the two strains when glutaraldehyde-
osmium was used. The outer membrane of rough strain RB51 was well-
defined using this procedure; in contrast, the outer membrane of the 
virulent, smooth 2308 was ribbon-like with electron dense inner surface. 
Ruthenium red intensified the staining of the external surface of the 
outer membrane of 2308. The nature of the outer cell wall was examined 
using outer membrane-enriched preparations that revealed "railroad track" 
structures (8 nm) that tended to be twisted. When live brucellae were 
injected intraperitoneally into mice, coccobacilli were found attached to 
and within macrophages. Adherent zones between bacteria and host cell 
surfaces contained microfilamentous material not present on non-adherent 
surfaces. Strain RB51 was present in phagosomes in greater numbers than 
its parental strain, 2308. Evidence of a pore-like structure was seen 
ultrastructurally in the adherence zone between bacterium and murine 
peritoneal macrophage. The ultrastructural characteristics of the cell 
wall contributes to the understanding of B. abortus by demonstrating 
surface components that may be involved in cellular interactions. 
Introduction 
Surface components are involved in cellular interactions (e. g . ,  
attachment, internalization, inhibition of phagosome-lysosome fusion, 
etc.) between host and parasite (30). Brucella abortus adheres to and 
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infects mononuclear phagocytes during the course of brucellosis in cattle 
(46). Bovine neutrophils also phagocytize Brucella and are more 
efficient at killing rough than smooth strains of B. abortus (41, 42). 
Brucella survive within phagocytic cells of the reticuloendothelial 
system where they are protected from antibody, complement, and 
antibiotics (12, 36, 37). Smooth brucellae are ingested less rapidly 
than rough, but do not kill the host cell and subsequently multiply 
partially protected in the phagolysosome. Survival and replication in 
host phagocytes, especially macrophages, is pivotal in the disease 
production by brucellae. 
Surface components of Brucella are involved in the virulence and 
pathogenesis of brucellosis (48). Smooth strains are more virulent than 
rough variants and are typical of Brucella isolated from natural 
infections (2). Brucella cultures tend to dissociate (smooth to rough) 
during growth on laboratory media or after repeated transfers, thereby 
reducing the quantity of 0-antigen of LPS. Comparisons between smooth 
and rough strains of Brucella suggest but ultrastructural analysis has 
not successfully been used to explore how loss of surface LPS component 
might be used in defining host response (13, 15, 27). However, rough 
cells are more pleomorphic, have more frequent bud formation of the 
cytoplasmic membrane, and have more numerous areas of contact between 
individual cells than smooth cells (13, 15). 
The Brucella cell wall consists of three layers: the inner or 
plasma membrane (cytoplasmic membrane), the periplasmic space containing 
peptidoglycan, and the outer membrane (18). The outer membrane forms a 
physical and functional barrier between the periplasmic space and its 
environment. Outer membranes contain lipopolysaccharide (LPS), proteins, 
and phospholipids. Peptidoglycan is strongly associated with the outer 
membrane. The major outer membrane proteins of B. abortus consist of 
porins of Group 1 (88-94 kd), Group 2 (35-40 kd), Group 3 (25-30 kd), and 
a lipoprotein (8 kd) linked to peptidoglycan (49, 34). Covalent linkage 
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between these proteins with smooth LPS has been h3rpothesized (34/52,82). 
Antigenic relatedness among porins of B. abortus has been demonstrated 
using antiserum produced in rabbits (49). Cell surface components, i.e., 
outer membrane proteins, capsules, toxins, enzjrmes, flagella, pili, and 
siderophores have been demonstrated as determinants of virulence for 
bacteria (8, 51). However, only LPS of Brucella has been implicated in 
the pathogenesis of brucellosis (43, 48). 
Antigenic determinants that are associated with the capsule (24, 
35) and outer membrane (49) play an important role in immune responses 
since they are involved in the initial interactions between host and 
parasite. They have a wide spectrum of activities, i. e., interactions 
with ions, macromolecules, viruses, and solid surfaces (natural, man-
made), and inorganic and organic materials (4). Schurig, et al. (44) 
suggest that immunogens located on the surface of the invading Brucella 
cell may be more important in modulating host's immune responses than 
internal antigens. For example, the 0-polysaccharide of the LPS molecule 
is immunodominant when compared to other antigens of the Brucella cell 
( 2 8 ) .  
'Electron microscopy has proved to be valuable for examining 
structural characteristics of bacteria. Special stains used in electron 
microscopic techniques are necessary for demonstration of bacterial 
surface morphology and properties (6, 23). In the present study, the 
cell envelope of a smooth virulent and a rough strain of B. abortus were 
examined. Brucella abortus strain 2308 is a smooth, virulent, 
laboratory-adapted field strain that is pathogenic to cattle. The rough 
strain, RB51, is a derived rifampin mutant of strain 2308, lacks the 0-
antigen of Brucella LPS, and is much less pathogenic than 2308. Brucella 
abortus strain RB51 has been proposed as a vaccine to replace strain 19 
which is currently used in the eradication program against brucellosis in 
domestic cattle (10, 45). The objective of this study is to use electron 
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microscopy to analyze ultrastructural cellular characteristics of B. 
abortus strains 2308 and RB51. 
Materials and methods 
Brucellae and cultivation. Bacterial strains were from stock 
collections at the National Animal Disease Center, Ames, Iowa. Brucella 
abortus strain RB51 was originally obtained from G. G, Schurig (Virginia 
Polytechnic Institute and State University, Blacksburg, VA) and was 
expanded to produce a new master seed stock referred to as "ARS/1". This 
stock has been used for experiments conducted in the Brucellosis Cattle 
Test Program at NADC. Brucellae were propagated on Tr3Tptose agar (Difco 
Laboratories, Detroit, MI) with 5% bovine serum for 44 h at 37° C. 
Brucellae were characterized using standard procedures for biotyping 
Brucella (2). ChlamydLa psittaci TT3 (Texas turkey strain; 38) was 
propagated in Vero cells (ATCC, Rockville, MD) as previously described 
(25). 
Murine peritoneal macrophages. Eight- to ten-week-old BALB/c mice 
were obtained from Harlan Sprague Dawley (Indianapolis, IN). Brucella 
afeortus-activated macrophages were obtained from mice that were injected 
intraperitoneally with 1 ml saline containing 10^ ° CFU of either 2308 or 
RB51 at 15 min or at 3 h prior to harvest. Mouse peritoneal cavities 
were lavaged with cold saline, peritoneal exudate cells were collected, 
and samples were processed for electron microscopy. Resident peritoneal 
macrophages were collected from saline-treated mice. Two or three mice 
per strain were used for each collection time and approximately 25 
peritoneal macrophages were examined per grid with a minimum of two grids 
examined for each sample. 
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Pre-paration of OMP-enriched fraction. Outer membrane-enriched 
fractions were prepared by modifications of previously published 
procedures (25, 49). Bacterial cells were disrupted by sonication (Heat 
systems-Ultrasonics, Inc., Farmingdale, New York); whole cells were 
removed by centrifugation (4,000 x g for 15 minutes). Two percent 
Sarkosyl (sodium N-lauroyl sarcosinate) (Sigma) in 20 mM Tris (pH 7.6) 
was added to the broken cell suspension (1:1), and incubated 30 minutes 
at 37° C, and a Sarkosyl-insoluble fraction pelletted by centrifugation 
(105,000 X g for 1 hr at 5 C) . The pellet was suspended in 10 mM HEPES 
(pH 7.2) containing 150 mM NaCl, 10 mM MgCl2, 100 /ng of RNase I-A per ml 
(Sigma), and 50 yitg of DNase I (Sigma) per ml (5). This suspension was 
incubated 30 minutes at 37° C, centrifuged (105,000 x g for 1 hr at 5 C), 
and the pellet, containing OMPs, suspended in HjO. Purity of OMP-enriched 
preparations was determined by electron microscopy using thin sectioning 
and negative staining techniques (6, 7, 23). 
Electron microscopy. Murine cell exudates or bacteria grown on 
agar were fixed with 2.5% glutaraldehyde in 50 mM sodium cacodylate 
buffer (ph 7.4) for 3 h, stained in 1% OsO^  for 2 h, dehydrated in graded 
ethanols and propylene oxide, and embedded in Medcast (Ted Pella, Inc., 
Tustin, CA). Sections (90 nm) were stained with lead citrate (40) and 
uranyl acetate (47). Ruthenium red staining was done as described above, 
except ruthenium red was added (50 mg/ml) to the glutaraldehyde fixative 
(6, 23). Brucellae for alcian blue fixation were fixed on the agar 
surface and then processed for electron microscopy (6, 23). 
Brucellae were stained with neutralized phosphotungstic acid and 
applied to coated copper grids with a nebulizer (7). All preparations 
were examined with a Philips 410 electron microscope (Philips Electronic 
Institute Inc., Mahwah, NJ) at an accelerating voltage of 60 kV. 
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Results 
Smooth B. abortus strain 2308 differed from rough B. abortus strain 
RB51 in the standard procedures for determining colonial morphology. 
Strain RB51 agglutinated in the presence of acriflavine, absorbed crystal 
violet, and was not lysed by Brucella bacteriophage (Tbilisi). 
Bacterial ultrastructure. Phosphotungstic acid-stained B. abortus 
strains 2308 and RB51 had convoluted or wrinkled surfaces with occasional 
vesicular structures protruding from the surface (Fig. 1). The surface 
of RB51 was less convoluted than 2308. Inner and outer membranes and 
their relationships with the periplasmic space was not visible. Strain 
RB51 cells were rod-shaped rather than coccobacillary as t3T)ical for 
2308. No flagellae, pili, sex pilus, capsule, microfilaments or other 
surface structures or appendages were seen. 
Thin sectioning revealed typical Gram-negative cell wall morphology 
with an outer membrane (6-8 nm) and a cytoplasmic membrane (7 nm) 
separated by a homogeneous electron-dense periplasm of variable thickness 
(5-30 nm). Brucellae were coccoid or coccobacilli in shape having a 
diameter of about 0.5 fim and a length between 1.0 and 1.4 /im. Distinct 
capsules were not seen on any brucellae. 
Thin-sections of glutaraldehyde-osmium fixed cells from both, 
strains showed the general inner and outer membrane structure (Fig. 2). 
The surface of RB51 had electron-dense inner and external leaflets of the 
outer membrane. In contrast, the outer membrane of 2308 was a ribbon­
like membrane, asymmetrically stained (the inner leaflet was more 
electron dense than the outer surface), and was of uniform width 
bordering the periplasm. Washing the 2308 cells with buffer before 
fixation did not enhance staining of the surface. The periplasmic space 
contained granular, electron-dense peptidoglycan layer in both strains 
and no qualitative or quantitative differences were detected between the 
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two strains. 
Ruthenium red intensified the staining of material (approximately 
10 ran) external to the outer membrane for both strains 2308 and RB51 
(Fig. 3). The inner leaflet of the outer membrane stained more intense 
by ruthenium red. The periplasm between the inner and outer membrane of 
both strains was granular and electron-dense. 
Osmium-fixed cells revealed no differences between 2308 and RB51 
(Fig. 4). Both strains showed highly convoluted or sinuous outer 
membranes with adhesion sites (Bayer junctions) between outer and 
cytoplasmic membranes. The outer face of the plasma membranes was often 
very tightly appressed to the periplasma and difficult to distinguish. 
The peptidoglycan layer appeared less granular and electron-dense, 
sometimes translucent. The cell interior of both strains contained the 
formation of irregular, thin, fibrillar chromatin-like network. 
Alcian blue fixation did not reveal any morphologically distinct 
capsule on either 2308 or RB51 (Fig. 5). The outer membrane of RB51 had 
electron-dense inner and external leaflets of the outer membrane. In 
contrast, the outer membrane of 2308 was a ribbon-like membrane with 
electron-dense inner surface. The peptidoglycan layer of 2308 and RB51 
was granular and electron-dense. 
Outer membrane preparations. Membrane vesicles were seen in OMP-
enriched preparation from B. abortus strain RB51 and C. psittacL strain 
TT3 (Fig. 6). The diameter of TT3 vesicles was determined to be 0.2 to 
0.4 um for intact membranes that retained native elementary body 
morphology with electron-dense staining of the external and inner 
surfaces of the membrane. Strain RB51 showed membrane fragments that 
tend to spiral. Membrane diameters were approximately 8.0 nm for both 
organisms. No cytoplasm, cytoplasmic membrane, or peptidoglycan-like 
structure was visualized in the OMP-enriched preparations. Spike-like 
projections were found in C. psittaci TT3 that extended through the 
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membrane. Projections in Brucella were not discernable. 
Murine peritoneal macrophages. At 15 m post intraperitoneal 
injection with brucellae, multiple Brucella cells were found within 
membrane-bound phagosomes of peritoneal macrophages from RB51-inoculated 
mice (Fig. 7). Peritoneal macrophages from mice injected with 2308 had 
none to few bacteria within cellular phagosomes (data not shown) . At 3 h 
post exposure, intracellular bacteria were seen within membrane-bound 
phagosomes of macrophages from 2308-inoculated mice (Fig. 8), but not in 
numbers as seen in macrophages from RB51-inoculated mice (Fig. 9). 
Electron-dense material was present in most phagosomes containing 2308. 
This material was rarely seen in phagosomes containing RB51. No bacteria 
were seen in resident peritoneal macrophages from saline-treated mice. A 
pore-like structure (diameter 20 nm) protruding (approximately 45 nm) 
from the outer membrane of RB51 was seen adherent to a peritoneal 
macrophage collected at 3 h PI (Fig. 10). The spike-like projection was 
5 nm in diameter. 
Attachment zones between bacterium and host cell were closely 
apposed with a regular intracellular space of 18 nm. Microfilamentous 
material spanned the space between the bacterium and host cell, and this 
material was not seen at non adherent sites on the bacterial surface. 
The host cell cytoplasm adjacent to adherent zones did not contain 
visible filaments of actin or other cytoskeletal components. However, 
clathrin-like aggregates were seen at these sites on the cytoplasmic side 
of the macrophage plasma membrane. 
Discussion 
This investigation demonstrated that B. abortus strain RB51 (rough) 
has surface component that differs ultrastructurally from 2308 (smooth). 
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Thus, the derivation of RB51 from 2308 (45) must result in a mutational 
event(s) which led to change of the phenotypic smooth to rough colonial 
morphology. Polymeric condensation of surface components on 2308 were 
visible when ruthenium red was present in the fixative, but surface 
components of RB51 remained on the cell surface during the processing for 
electron microscopy. This difference in staining between 2308 and RB51 
reflects phenotypic expression of these two strains. The surface 
components of RB51 may represent modifications in the acidic 
polysaccharides associated with LPS. A mucopeptide complex has been 
demonstrated in B. abortus strain 2308 that is not present in strain 19; 
this complex has not been successfully implicated in the pathogenesis of 
Brucella in cattle (26). 
Dissociation to the rough variant may indicate an alteration in 
permeability and/or structures of the cell surface, walls, or membranes. 
Long side-chains of LPS 0-antigen have been shown to causes stearic 
hinderance in the accessibility of some proteins on smooth strains of 
Brucella (11). Surface exposure of specific outer membrane proteins was 
demonstrated in rough strains of Brucella but not in smooth strains using 
monoclonal antibodies and immunogold labeling for electron microscopy. 
In the present study, greater nvimbers of RB51 than 2308 were phagocytosed 
by murine peritoneal macrophages. The somatic antigen(s) of the outer 
membrane covering the bacterium possibly makes 2308 more hydrophobic than 
mononuclear phagocytes, thus interfering with the host immune response 
(14). Monocyte-derived macrophages pretreated with an extract of RB51 
containing outer membranes and peptidoglycan inhibits the entry of B. 
abortus (9). 
Bacterial cell surface molecules that bind specific mammalian host 
cell surface molecules and promote phagocytosis without resisting 
intracellular activities would usually be degraded or eliminated. 
Surface factors associated with LPS of smooth brucellae permit 
intracellular survival of B. abortus by inhibiting phagolysosomal fusion, 
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resisting lysomal attack, or resisting oxidative attack (39). Entry into 
the macrophage by bacteria which suppress or avoids stimulation of 
oxygen-dependent or oxygen-independent killing mechanisms enhances 
intracellular suxrvival. The intracellular survival and replication rates 
for 2308 are significantly higher than those for the rough B. abortus 
strain 45/20 (20). Brucella, endotoxin (LPS) has been implicated in the 
pathogenesis of brucellosis (1, 29). 
Brucella outer membrane-enriched preparations showed membranes that 
were similar in structure to that of the insoluble cell-wall fraction of 
B. abortus strain 99 (smooth; 16, 17). The outer membrane-enriched 
preparations of RB51 contained membrane fragments that tended to be 
spiral-shaped or twisted. Comparison with outer membranes from 
C.psittacl strain TT3 showed membranes with retention of native 
elementary body morphology. Peptidoglycan of many Gram-negative bacteria 
give the cell wall its rigidity (50). However, C. psittaci cells do not 
contain peptidoglycan in their cell walls; instead outer membranes of 
elementary bodies have proteins that are disulfide cross-linked (19, 21, 
22, 31, 32). Outer membranes of C. psittaci contain proteins that 
incorporate cysteine during the development of elementary bodies and 
these proteins are involved in the rigidity of elementary bodies (21). 
Spike-like projections were found in C. psittaci TT3 that extended 
through the membrane. These structures have been implicated in the 
attachment of elementary bodies to prospective host cells or may 
represent formation of nutrient-sequestering mechanisms for acquiring 
metabolites from the host, thereby functioning as pores (porins) (33). 
The projections seen with RB51 that extended from the bacterial outer 
membrane through the membrane of a murine peritoneal macrophage (Fig. 10) 
may represent similar adhesin or pore-like structures. 
Intraphagosomal accumulation of brucellae were predominant in our 
study as we did not find Brucella cells in other organelles of the 
macrophage. In a caprine model of placentitis (3), strain 2308 was 
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demonstrated in the rough endoplasmic reticuliim (RER) of chorioallantoic 
trophoblasts where brucellae could use the specialized functions of 
trophoblastic RER for synthesis and glycosylation of bacterial proteins, 
thus enhancing intracellular replication. Lack of brucellae in the RER 
of murine peritoneal macrophages suggests that B. abortus does not need 
enzymes or other products (e.g., proteins, amino acids) of the RER for 
replication in macrophages. Alternatively, it may reflect that at 3 h PI 
there was no need for an increased level of posttranslational protein 
modification for intracellular replication at this sampling time. 
Further studies are needed to investigate receptor affinities and 
quantitation of receptor molecules on cell surfaces. Immunocytochemical 
techniques for localizing various constituents of the cell wall will help 
determine the functions of the surface structures demonstrated in this 
study. In addition, information gained may help resolve questions 
concerning the fate of brucellae in the host; more specifically, the 
carrier state which leads to initiation or maintenance of bovine abortion 
due to B. abortus may be answered. 
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Phosphotungstic acid-stained preparations of B. 
abortus strains RB51 (A) and 2308 (B). Bars, 
0.1 nm. 

FIG, 2. Thin sections of B. abortus strains 2308 (A) and RB51 (B) 
fixed with glutaraldehyde and osmium. Bars, 0.1 fim. 

FIG. 3. Ruthenium red-stained preparations of B. abortus strains RB51 
(A) and 2308 (B). An approximately 10 nm-thick layer at the 
surface was heavily stained with ruthenium red. Bars, 
0.1 fim. 

FIG. 4. Osmiiim stained preparations of B. abortus strains RB51 (A) 
and 2308 (B). Bars, 0.1 fim. 

FIG. 5. B. abortus strains EIB51 (A) and 2308 (B) stained with alcian 
blue. Bars, 0.1 /im. 

FIG. 6. Outer membrane morphology. Outer membrane protein-enriched 
preparations extracted from B. abortus strain RB51 (A) and 
elementary bodies of Chlamydia psittaci strain TT3 (B). 
Membrane diameter is 8 nm and vesicle diameters are 
approximately 0.4 to 0.6 fim. Bars, 0.1 /xm. 

FIG. 7. Electron micrograph of a murine peritoneal macrophage at 15 m 
PI with B. abortus strain RB51. Bar, 1.0 fim. 
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FIG. 8. Electron micrograph of a murine peritoneal macrophage at 3 h 
PI with B. abortus strain 2308. Bar, 1.0 /itm; inset bar, 
0.1 /xm. 

FIG. 9. Electron micrograph of a murine peritoneal macrophage at 
3 h PI with B. abortus strain RB51. Bar, 1.0 /xm. 
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FIG. 10. Bacterium attached to a murine peritoneal macrophage at 3 h 
PI with B. abortus strain RB5I. Bars, 0.1 /im. 
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GENERAL SUMMARY AND DISCUSSION 
The widespread use of live Brucella as a vaccine requires detection 
systems that allow for a reliable identification of the vaccine strain as 
well as differentiation from field isolates. The data shown in this 
investigation confirms that pulsed-field gel electrophoresis (PFGE) 
analysis was a reliable tool not only for the specific detection of the 
proposed vaccine B. abortus strain RB51, but also for typing isolates of 
Brucella to the species level. 
Few studies have characterized the genome of B. abortus. The 
genomic fingerprint of RB51 has never been reported. In this study, PFGE 
was used to fingerprint brucellae and a method was developed to 
differentiate RB51 from other brucellae. Genomic restriction 
endonuclease analysis of brucellae was detemined using pulsed-field gel 
electrophoresis to separate fragments of DNA that were produced by 
digesting the genome with Xba I. 
Pulsed-field gel electrophoresis was used to obtain fingerprints 
from field isolates of B abortus and the proposed vaccine strain RB51. 
The focus was principally on B. abortus isolated from cattle, but also 
included field isolates of B. abortus from bison and elk, reference 
strains and biovars of Brucella, vaccinal strains, as well as 
genetically-engineered brucellae. The PFGE profiles of the reference 
type strains allowed separation of the strains to the level of species. 
A unique fingerprint relative to other brucellae was discovered for RB51, 
using PFGE profiles of genomic DNA digested with the restriction 
endonuclease Xba I. 
The distinction of Brucella species by use of PFGE correlated with 
the preferred natural host specificity, growth characteristics, and 
serologic and bacteriologic methods used to classify Brucella species. 
Results indicated that biovars of B. abortus did not greatly vary in 
their PFGE fingerprints, and this was suggestive of an evolutionary 
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adaptation of this species. It's reasonable to assxjine that as long as 
environmental factors (ie, natural host) are stable, the genotype will 
continue. 
Direct examination of restriction endonuclease digest patterns 
(fingerprints) of brucellae offers a rapid and reproducible method for 
the characterization and classification of isolates applicable to 
ecological, etiologic, epidemiologic, and population genetic studies. 
Accurate identification and discrimination of RB51 from other brucellae 
are the preconditions to assess vaccination success and to prevent 
further dissemination of possible pathogenic brucellae. 
The stability of RB51 as determined by using fingerprinting and 
standard methods for characterizing brucellae were investigated. The 
genomic profile of RB51 was unique from Brucella isolated from cattle, 
bison, and elk. Results indicated that the genomic fingerprint, 
oxidative metabolism, and rough colonial morphology of RB51 were stable 
characteristics and can be used to differentiate this potential vaccine 
candidate from other isolates of Brucella from infected cattle, bison, 
and elk. 
Absence of noticeable differences in banding patterns of B. abortus 
isolated from bison and elk indicated that these isolates were clonally 
related. The important finding was the monomorphism in B. abortus from 
bison and elk and in B. abortus biovars 1, 2, and 4 isolated from cattle, 
regardless of geographical origin (within USA) or host (cattle, bison, or 
elk). Similar profiles did not necessarily indicate that the isolates 
were the same; but suggested that strains of B. abortus which are limited 
in nature to the bovidae were closely related to the strains which can 
replicate in elk. 
The Warburg respirometer was used to determine the oxidative rates 
for RB51 before and after in vivo or in vitro passage. This apparatus 
measures the ability of a Brucella isolate to metabolize amino acid and 
carbohydrate substrates by vol\imetric measurements of oxygen consumption. 
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No change in the characteristic profile of B. abortus for oxygen uptake 
on selected amino-acid and carbohydrate substrates were demonstrated for 
RB51 after in vivo or in vitro passage. 
Strain RB51 maintained rough characteristics after in vivo and in 
vitro passages. No expression of the 0-antigen of Brucella was detected. 
The described observations suggest that RB51 has the potential of being 
used as a protective, live vaccine which would not elicit the 0-antigen 
specific antibodies that interfere with standard serological assays for 
diagnosing brucellosis, so it could be used in the National Brucellosis 
Eradication Program. 
Genomic fingerprints of reference strains and biovars of Brucella 
were analyzed using PFGE to evaluate the genetic relatedness among the 
strains of Brucella. Included were four recently described isolates of 
Brucella from the coiranon seal, harbor porpoise, and the common dolphins. 
The PFGE profiles of the isolates from marine mammals were different than 
those of the six recognized species of Brucella. The two isolates from 
dolphins had similar profile to each other but distinct from those of the 
isolates from seal and porpoise. 
Profiles generated from PFGE of Xba I digested DNA were easily 
interpreted and provided data which could be standardized between 
laboratories. Results supported the designation of an additional genomic 
group(s) of Brucella based on published reports, genomic fingerprint, and 
the trait of a preferential host for each Brucella species. The 
bacterial isolates from marine mammals represented atypical strain(s) or 
species of Brucella that have adapted to the marine environment (host-
adapted) and are possible products of (recent) evolutionary changes that 
have occurred in isolated bacterial populations. 
Genomic macrorestriction endonuclease fingerprinting using PFGE 
considers the overall organization of the bacterial genome and may be an 
indicator of clonal origin and genetic relatedness. It is conceivable 
that although most genomes of Brucella species identified as members of 
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the same clone are Identical or nearly so, some may have different 
ancestries and derived by horizontal (transmissible) transfer from other 
clones of the same or different species. 
Brucella abortus strains RB51 (rough) and 2308 (smooth) were 
characterized using electron microscopy. Cell wall structure was 
examined using negative staining with phosphotungstic acid and thin-
section techniques which included glutaraldehyde-osmium, ruthenium red, 
alcian blue, and osmium staining procedures. The known virulence of 
smooth brucellae compared to rough implied that surface structures play 
an important role. The dramatic difference between the extracellular 
environment and the milieu established within a eukaryotic cell, denotes 
that the bacterium is capable to respond to this abrupt change adapting 
as an intracellular pathogen. Possible structural elements in this 
process were elucidated in this study. 
The synthesis of smooth LPS by brucellae is the most obvious 
difference between B. abortus strains 2308 and RB51 which may have 
accounted for the structural differences that were demonstrated by 
ruthenium red and glutaraldehyde-osmium procedures; specifically acidic 
polysaccharides associated with the smooth LPS. In addition, the 
presence of spike-like structures protruding from the outer membrane were 
demonstrated. The function of these spike-like projections was not 
determined. The outcome of the early stages of infection with Brucella 
appear to be related to receptor-mediated events that culminate in the 
attachment and invasion of bovine cells. Perhaps the spike-like 
structures serve as an adhesion for attachment to the host cell 
(receptor-mediated process) in the early phases of brucellosis or maybe 
used as a pore to allow the transport of nutrients or metabolites across 
cell membranes. These two motifs, for adherence and transport, remain 
the subjects of future studies. 
The studies presented in this dissertation contributes to the 
characterization of RB51. Since this was primarily a fingerprinting 
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Investigation, results identified individual strains (or groups) of 
Brucella using chromosomal fingerprinting techniques. The attention was 
primarily on B. abortus which included field, wildlife, vaccine, and 
reference strains as well as genetic-engineered brucellae. Results were 
used in conjunction with existing methods of biotyping Brucella and 
compared with published reports on genomic analysis of Brucella. PFGE 
permitted discrimination of B. abortus strain RB51 from other brucellae. 
The reliability of bacterial markers for epidemiological investigations 
depends on diversity and reproducibility; this method of genomic 
"fingerprinting" by means of PFGE provided an effective and specific 
epidemiological tool for pursuing the source and possible spread of the 
vaccine strain RB51. 
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ENUMERATION OF BRUCELLA ABORTUS RB51 IN SUSPENSION 
A turbidimetric method was used to estimate the number of Brucella 
abortus strain RB51 organisms in a saline suspension. This was based on 
the degree of light-scattering by B. abortus RB51 in suspension which was 
used to estimate the concentration of organisms. Standardized methods 
for preparing the bacterial suspensions were developed. Brucella abortus 
strain RB51 was grown for 40-44 h at 37°C on tryptose agar. Cells were 
removed from the agar surface using 0.85% NaCl and suspensions with 
different turbidities were prepared. Turbidity was measured using a 
spectrophotometer (Spectronic 20, Bausch and Lomb, Rochester, NY) at a 
wavelength of 600 nm. Spread plate colony counts were used to count 
viable, colony-producing cells for each suspension. 
A reference scatter plot was prepared by plotting the absorbance of 
light against the viable count per ml. The regression line was used as 
an estimator of the concentration of subsequently prepared suspensions of 
B. abortus strain RB51 cells. Using B. abortus strain 2308, an optical 
density of 0.125 at 600 nm represented approximately lO' CFU/ml of 
suspension (personal communication with B. L. Deyoe, NADC). 
Strain RB51 was grown 44-48 h on tryptose agar, removed from the 
surface of the agar using WHO lyophilization medium (5), and 
concentration was determined before lyophilization using the technique 
described above. Aliquots of the cell suspension containing 50 billion 
CFU were placed into 10-ml injection vials and then frozen at -80°C. 
These frozen cells were lyophilized at a vacuum of 110 militorr using a 
lyophilizer (model # 10-030; The Virtis Company Inc, Gardiner, NY). 
Viability following lyophilization was determined at 1 and 3 months 
storage at -20°C or room temperature. At 1 and 3 months after 
lyophilization, cells were rehydrated (10 ml) and standard plate counts 
were made to determine concentrations of viable cells. Less than 5% loss 
of the original cell count was demonstrated. 
Enxjuneration of Brucella abortus strain RB51 in suspension. 
Absorbance (ODggo) of a saline suspension of RB51 was plotted 
against the viable colony forming units (CFU) per ml. 
Estimation of the number of RB51 in suspension is determined 
by measuring the turbidity and using the regression line to 
calculate the predicted concentration. 
CFU/ml (x billion) 
"T" 
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BRUCELLIN 
Brucellin preparations were extracted by modifications of 
previously published procedures (5). Brucellae were grown on tryptose 
agar (Difco Laboratories, Detroit, MI) in Roxix bottles for 3 days at 37°C. 
Cells were harvested using PBS (pH 7.2), precipitated with 2 volumes of 
acetone at -20°C, and then held at that temperature for 24 h. Cells were 
pelleted by centrifugation, washed three times with acetone (-20°C) , and 
dried under vacuum. Dried cells were suspended in 2.5% NaCl to make a 5% 
suspension (w/v), stirred 3 days at 4°C, and removed following 
centrifugation. Cold ethanol was added (3:1) to the supernatant. The 
precipitate was pelleted by centrifugation, dissolved in HjO, and 
centrifuged (105,000 x g) for 6 hours at 5°C. Supernatant was lyophilized 
and constitutes the brucellin. Biological activity in cattle was 
assessed by intradermal injections of brucellin. Results have been 
reported (23). 
Table 1. Brucellin yield 
Characteristic 2308 Brucellin RB51 Brucellin 
Brucellin yield (mg) 769.10 330.55 
% Yield (dry weight) 20.07 11.48 
% Protein (dry weight) 76.33 54.47 
% Protein of whole cell 15.32 6.25 
FIG. 1. Proteins separated by sodivun dodecyl 
sulfate-polyacrylamide gel electrophoresis 
(SDS-PAGE). Lane 1, molecular weight standards; 
2, purified 31 kd protein; 3, 2308 brucellin; 4, 
RB51 brucellin; and 5, 20 kd superoxide dismutase 
(SOD). Gel ran at a constant current of 35 mA 
for 1.5 hr and at 100 mA for 2-3 hr. Protein 
bands visualized by Coomassie brilliant blue R250 
(Biorad Laboratories, Richmond, CA). Molecular 
weight sizes are indicated at left. 
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FIG. 2. Immunoblot analysis of brucellin with monoclonal 
(A, B) and rabbit polyclonal (C, D) antibodies. 
A, C) lane 1, brucellin; 2, molecular weight 
standards; 3, purified 31 kd protein; and 4, 
strain 19 whole cell preparation. B, D) lane 1, 
purified 20 kd superoxide dismutase (SOD); 2, 
strain 19 whole cell preparation; and 3, 
brucellin. Immunocomplexes detected using 
biotinylated rabbit anti-mouse or rabbit IgG 
(Zymed Laboratories, San Francisco,CA), followed 
by avidin-biotin complex reagent (Vectastain, 
Vector Laboratories, Burlingame, CA), with 4-
chloro-l-naphthol as the substrate. Molecular 
weight sizes are at left. 
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FIG. 3. Immunoblot analysis of brucellin with cattle 
sera. Brucellin protein were separated by SDS-
PAGE, electrophoretically transferred to 
nitrocellulose, and reacted with sera from cattle 
vaccinated with RB51 (lane 2), strain 19 (lane 
3), 19-31 kd (lane 4), or challenged with 2308 
(lane 5). Lane 1, brucellin proteins stained 
with India ink. Immunocomplexes detected using 
biotinylated rabbit anti-bovine IgG (Zymed 
Laboratories, San Francisco,CA) , followed by 
avidin-biotin complex reagent (Vectastain, Vector 
Laboratories, Burlingame, CA), with 4-chloro-l-
naphthol as the substrate. 

